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1. INTRODUCTION 
  Siddha system of medicine is one of the traditional systems of medicine in 
India originated in the State of Tamilnadu. Siddhars are a group of Tamil Scientific 
philosopher endoured with supernatural powers who revealed their revolution to save 
the humanity. They are men with extra ordinary intelligence, high culture, noble 
thinking and sound experience. 
  “lXh<hK!dmz<!Ofib<!lVf<okeziGl<!
! lXh<hK!dtofib<!lVf<oke!siZl<!
! lXh<hK!-eq!Ofib<!uivi!kqVg<g!
! lXh<hK!siju!lVf<oke!ziOl”!
. kqVlf<kqvl<!
!
!! One that cures physical ailment is medicine 
 One that cures psychological ailment is medicine 
One that prevent ailment is medicine  
One that bestows immortality is medicine 
  Preparations based on naturally occurring materials have been employed by 
trial and an error since time immemorial, for combating human ailments. Thus all the 
traditional system of medicine are primarily in plant, animal and mineral sources.  In 
Siddha medicine there are used in the form of crude powder, parpam, tablets, 
decoction paste etc., 
  According to the basis of Siddha system, the universe consists of five senses 
of the human body. Man consumes water and food, breathes air and maintains the 
heat in the body.  He is alive because of the life force given by ether. The earth is the 
first element  which gives the shape to the body including bones, tissues, muscles, 
skin, hair etc., fire the third element that gives emotion, vigour and vitality to the 
body.  It also helps digestion, circulation and stimulation besides respiration and the 
nervous system. 
 
Concept of Treatment: 
  The treatment in Siddha system is aimed at keeping the three humors in 
equilibrium and maintenance of seven elements. So proper diet, medicine and 
disciplined regimen of life are advised for a healthy living to restore equilibrium of 
humours in diseased condition. 
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Treatment is classified into three categories: 
  Devamaruthuvam (Deivine method) In divine method, medicine like parpam, 
chenduram, guru, kuligai made of rasam, gandagam and padanams are used.  in 
surgical method, aruvai, Karanool Sluduthal are used.  In the rational method, 
medicines made of herbs like churanam kudineer, vadagam are used. 
  The Siddhars were those, who had renounced the world after experiencing its 
instability and uncertainty. They practiced the eight kinds of yogas and great miracles 
with divine power and ultimately attained the stage of perpetual consciousness or 
samathi and enjoyed eternal bliss. 
  The contribution of Siddhars, to Siddha literature with its boundless 
therapeutics and wonderful pharmaceutical preparation of medicine is acclaimed for 
excellence (Pre-eminent) even in the 20th century and worthy of its remarkable results. 
The siddha treatment deals and not only as a curative but also a preservative, taking 
care of the external body with its internal being soul. 
  The physiological function in the body is mediated by three substances 
(Mukkutram) which are made upto five elements. The mukkutram are Vatham, 
Pitham, and Kabam.  In each and every cell of the body.  These three doshas coexist 
and function harmoniously. 
1. Vatham is formed by Akasathin Vayu.  Vatham controls the nervous 
actions such as movement, sensation etc., 
2. Pitham is formed by thee (Fire) pitham controls the metabolic activities of 
the body, digestion, assimilation, warmth etc., 
3. Kabam is formed by Mann and Neer, Kabam controls stability. 
  Universe consists of two essential entitles, matter and energy. The siddhars 
call them Shiva (Male), Sakthi (Female) creation. Matter cannot exist without energy 
inherent in it and vice versa, the two co-exist are in separable. 
Justification of the drug: 
  It is a herbal component of medicine (Karuveppilai Chooranam). It cures 
diarrhoea, indigestion. As a student of Nanju Nool Dept.  It is our prime duty to prove 
safety of the drug by conducting acute and chronic toxicity studies.  Hence I took 
topic for my dissertation. 
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2. AIM AND OBJECTIVES 
AIM: 
         The main aim of this study is to access the safety of the drug “Karuveppilai 
Chooranam” on  wistar rats under various dose levels of drug administration 
especially in acute and sub acute toxicity studies.  
 
OBJECTIVE: 
 To collect the literature and other evidences of each ingredient on 
pharmacological and toxicological aspect.  
 To collect and purify the raw drugs according to literature evidence.  
 To prepare the medicine based on the procedure quoted in literature.  
 To establish the acute and sub acute toxicity of the drug. 
 To evaluate the biochemical analysis of the drug. 
 To analysis the haematological  investigations and histopathological study of 
the organs such as kidney, liver, heart and brain in wister rats. 
 To create an awareness among the practitioners of siddha to go for further 
study regarding the adverse effect in the drug.  
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3. REVIEW OF LITERATURE 
3.1. SIDDHA ASPECT 
2/!ofz<zqLt<tq< << << < !
!
-kx<G!“ofz<zqLt<tq”!we<X!ohbi</!!gile<!Ohie<X!npG{<mig<Gukqz<!
-K! sqxh<HjmbK/! ! -K! Kui<h<hq?! Gtqi<s<sqB{<mig<gq! lx<Xl<!
sqXfQIh<ohVg<gqbigUl<!osbz<hMgqe<xK/!
! ofz<zqg<gijbh<!hgx<OhiK{<{z<?!ouxq?!JbOfib<?!hQeqsl<?!uib<fQI!Svh<H?!
uif<kq?!lbg<gl<?!kjzs<Spzz<?!hqvOlgl<!-ux<jx!G{h<hMk<Kl</!
!
! hqk<kle!jubl<!hQfqsl<uib<!fQI!uif<kq!
! lk<klzg<!giMl<!lbg<gLlqz<!.!yk<kUV!
! uqz<zqg<gi!bl<lVr<gi!ole<eim<gi!uf<Oki<f<Ok!
! ofz<zqgi!bl<lVf<!K{</!
. Okve<!G{uigml<!
ofz<zqg<gib<g<!Gh<hqk<kl<!fQr<G!lke<Htqh<hiz<!
osz<ZOl!uiklkqx<!Osi<Kuviz<!.!osiz<Zjlbl<!
YMlqjks<!sqk<kk<kqz<!de<e!neZmOe!
%Mhqx!OlgLl<!Ohir<%X/!
!
-z<zi!lzg!lqv{<M!lbqe<xiOe!
bqz<zi!lzglqVg<GOl!.!-z<zilz<!
uijpg<!geqBl<!UjmB!lqPK!L{<hie<!
uijpg<!geqBt<!juk<k!ue</!
. Okve<!blg!ou{<hi!
ofz<zqLt<tqbqe<!G{l< < << < << < < <!
Ngue!zR<sgq!nsqi<g<oge<H!Vg<gqg{<O{ib<!
kig!Lkqvuqk<kf<!kiKf]<ml<!.!Olgk<kqe<!
-z<zqLt<tq!OhizVgz<!w{<gi!lqbuqbr<gl<!
ofz<zqLt<tq!bix<Ohi!fqje/!
. Okve<!G{uigml<!
fiUg<Gs<! Sjujbk<!kVgqe<x!ofz<zq!Lt<tqbiz<?!dm<$M?! wZl<HVg<gq!
Ofib<?! GVkqbpz<! Ofib<?! ohVl<hiM?! ouxqOfib<?! fQvVgz<?! uif<kq?! out<jt?!
N{<Gxqg<!ogih<Htl<!Ngqbju!uqzGl</!
! !
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gVofz<zq!lvk<kqe<!G{l<< < < << < < << < < <!
hkqjef<!okER<se<eq!hikf<!kbg<gl<!
lkqjef<!kqms<!osb<uqje!liEl<!.!hkqbqx<!
seqk<k!gVUVk<!kiEl<Ou!xiGf<!
keqk<kgV!ofz<zq!lvk<kiz<!
. Okve<!G{uigml<!
Lh<hq{q!ujggt<!biux<jxBl<! Ohig<Gl</! !dmjz!npqbilx<! gig<Gl</!!
-keiz<!leg<gtqh<H!d{<mig<Gl</!
!
ofz<zqLt<tqbqe<!ohiK!lVk<Kuh<< < < < << < < < << < < < <!hbe<<<<gt<<<<!
 &h<hjmf<kuVl<! -tjlBjmb! lih<hqt<jtjb! Ohiz<! npGme<!
-Vg<gOu{<ce<?!ofz<zqgeqjb!higR<!osb<K!d{<[kz<!Ou{<Ml</!
 ofz<zqg<gijb!Kjubz<!osb<K!sih<hqm?!Sjubqe<jl?!uif<kq!-jujbh<!
Ohig<Gl</!
 ofz<zq!ux<xjz!GcfQI!osb<K!ogiMg<g!lbg<gl<?!kigl<?!yg<gitl<!-ju!
fQr<Gl</!
 -jzg<!ogiPf<jk!njvk<K!Oliiqz<!gzf<K!sQkg<gpqs<sZg<G!kvzil</!
 3211!gqvil<! ofz<zq!ux<xjz! 55?911!lqzq!k{<{Qiqz<! Ohim<M! wm<cz<! yV!
hr<G!ux<xjuk<K!uck<kqXk<kkqz<?!966!gqvil<!si<g<gjvjbg<!%m<ch<!hiG!
osb<K! nkqz<! nkqlKvl<?! %jgfQI?! Lf<kqiqh<hpl<! ujgg<G! 81! gqvil<?!
Ohiqs<sl<hpl<?! kqh<hqzq! ujgg<G! 216! gqvil<! -jugjt! njvk<K!
ofb<uqm<Mg<gq{<c!olPGhkk<kqz<!Oke<uqm<M!hqjsf<K!He<jeg<gib<!ntU!
ogit<t!uif<kq?!gilijz?!hi{<M?!Ge<ll<!kQVl</!
.!G{himl<!&zqjg!
 ofz<zqLt<tq?! uqz<ul<?! Sg<G?! sQvgl<?! ofx<ohiiq?! sqx<xiLm<c! Oui<!
-jugjt!ye<X!%m<c!GcfQI!osb<K!hVgqz<!hqk<k!sk<kq!fQr<Gl</!
 ofz<zquqjkjbg<! ogi{<M! uf<K! ofiXg<gq! nkEt<tqVg<Gl<!
hVh<jhh<obMk<K! giz<hzl<! uQkl<! sih<hqm<M! uv! $M! yg<gitl<! -ju!
fQr<Gl</!
 yV!hzl<!ofz<zqOujvg<!ogi{<M!uf<K!)1/2!hc*!\zk<kqz<!Ohim<M!)2/5*!!
hcbigg<! gib<s<sq! gijzbqz<! sih<hqm<M! uv! hqk<kl<?! kigl<?! uif<kq!
-jugt<!kQVl</!!lzl<!fe<xigg<!gpqBl</!
 -v{<Mhc! ofz<zqg<gijbg<! ogi{<M! uf<K! dvzqz<! Ohim<M! Kjuk<K!
ogim<jmjb! fQg<gq! nkx<Gh<! OhiKlie! lqtgiBl<! dh<Hl<! Osi<k<Kh<!
hqjsf<K! wZlqs<sr<gib<h<! hqvliel<! dV{<jmosb<K! njmk<km<c!
oubqzqz<! dzIk<kq! juk<Kg<ogi{<M! Okjubie! OhiK! yV! njmjb!
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Kjubz<! osb<K! sikk<OkiM!dhObigqg<g! ghOvigl<?! lzg<gm<M?! uif<kq!
-jugt<!kQVl</!
. Ogi]ibq! nEOhig! juk<kqb! hqvl<l!
vgsqbl</!)-v{<mil<higl<*!
 ofz<zqg<gib<?!kie<xqg<gib<?!gMg<gib<?!lqtG!-jugjt!-Vfipq!fQIuqm<M!
wm<omie<xig<!gqbipl<!uck<K!&e<xil<fit<!Gcg<Gl<OhiK!Sg<G?!kqh<hqzq?!
lqtG!&e<Xl<!siqobjmbib<h<!ohick<K!yV!sqm<cjgh<!Ohim<M!ogiR<sl<!
Oke<uqm<M!Gcg<gUl</!!=jt?!-sqU?!Olgs<$M!-jugt<!k{qBl</!
. Ogi]ibq! nEOhig! juk<kqb! hqvl<l!
vgsqbl<!)Lkz<higl<*!
. !
ofz<zqLt<tq!OsVl<!hqx!lVf<Kgt<< < < < << < < < << < < < <!
2/n]<mikq!GcfQI< Q< Q< Q !
kQVl<!Ofib<gt<;!Q < < <Q < < <Q < < < hqk<kl<?!gqXgqXh<H?!uif<kq?!uqg<gz<?!d]<{uiB?!nsQv{l</!
. wtqb!juk<kqb!Ljxgt<!911!
Ngue!zR<ssqn!SIg<oge<H!Vg<gqg{<O{ib<!
kig!Lkqvhqk<kf<!kiKf]<ml<!.!Olgk<kqe<!
-z<zqLt<tq!Ohiz<!nVgz<!w{<gi!lqbuqbr<gl<!
ofz<zqLt<tq!biIOhi<!fqje/!
! -KUlK!
fz<zofz<zq!Lt<tqbX!fig<Gg<!GVsqkVl<!
nz<zz<uqiq!hqk<kl<!ngx<Xl<!njk!–!olz<zk<!
kjzLPgg<!g{<GtqVf<!kiUhqk<k!uif<kq!
-jubqpqOl!Sr<gTl<Ohil<!w{</!
. hkiIkG{!sqf<kil{q!&zLl<!djvBl</!
3/nkqlKvs<!$v{l<< << << <!
kQVl<!Ofib<gt<! ;!uif<kq?!nOvisgl<?!sqk<kh<hqvjl!
. sqgqs<sivf<kQhl<!juk<kqb!sqf<kil{q!
! !
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3/!Yll<<<<!
! Yll<! giIh<H! Sjujbg<! ogi{<Mt<tK/! ! hsqk<kQk<K~{<c?! -squgx<xq?!
ngm<Muib<ugx<xq?!nPgzgix<xq!Ngqb!osb<jgjbg<!ogi{<Mt<tK/!
! JbSvl<?! -Vlz<?! osiqbilf<kl<?! ohiVlz<?! gpqs<sz<?!Dpq?!Gmzqjvs<sz<?!
-jvh<H?!hz<Ofib<?!Gb<bOvigl<!-jugt<!Ohil</!
! sQkSvr<!gisR<!osiqbilf<!kl<ohiVlz<!
! Ohkqbqjvs<!sz<gMh<H!Ohvill<!.!YkqbqVlz<!
! hz<oziMhz<!&zl<!hglqjuOfi!obe<osBOli!
! osiz<oziMOhil<!Yloles<!osiz</!
. ngk<kqbi<!G{uigml<!
Ylk<kqe<!lVk<Kuh<!hbe<gt<< < < < < << < < < < << < < < < <!
 Yll<?! Sg<G?! sqk<kqv&z! Oui<h<hm<jm! -ju! &e<Xl<! Yovjm! ohick<K!
ye<Xgzf<K?! gzf<k! wjmg<G! Ofi<! gMg<gib<h<! ohic! %m<c! Oujtg<G!
&uqvz<!ntU!Oliiqz<!ogiMg<g!lf<kl<!fQr<Gl</!
 Yll<?! gMg<gib<! Okiz<?! Lg<gMG?! sqx<xvk<jk!ng<gqvgivl<?! kqh<hqzq! Oui<!
-jugtqe<!ohic!Yovjm!%m<cb!wjmg<G!Ofi<!hikq?!sIg<gjv!Osi<k<K!
gijz!lijz!&uqvz<!ntU!ogit<t!HjgbqVlz<!kQVl</!
 Yll<?! lqtG!ujgg<G! 45! gqvil<!-ux<jx!ouKh<hq?! ouz<zl<! 45! gqvil<!
Osi<k<kjvk<K?! gijz! lijz! 21! fit<! ogim<jmh<! hig<gtU! sih<hqm!
ubqx<Xg<gMh<H?!ohiVlz<?!gpqs<sz<!kQVl</!
 4511! gqvil<! K~{qfQiqx<! Osi<k<K! wm<cozie<xib<! uck<K?! nkqz<! si<g<gjv!
451gq! gjvk<K! hiG! osb<K?!nLg<gqvig<gqpr<G?! Gg<gqz<?! hxr<gqh<hm<jm?!
giIOhigiqsq! ujgg<G! 45! gqvil<! ohick<Kk<! K~uq! fX! ofb<! fipq!
uqm<Mg<gq{<c?!-OzgqbR<! osb<K! Oujt!ye<Xg<G! 7!gqvil<! wjm!uQkl<!
ogit<t!hxr<gqs<$jz?!sqvr<G?!H{<?!gvh<hie<?!uiB?!fR<S!gcgt<!kQVl</!
 Yll<! 363! gqvil<! NmiOkijms<siX?! -R<sqvsl<?! hpvsl<?! Hkqeis<siX!
ujgg<G!246gq!-f<Kh<H!45!gqvil<!OsIk<K!Dx!juk<K!dzi<f<k!-Vlz<?!
Suisgisl<?!nsQv{l<!Ngqbe!fQr<gg<!ogiMg<gzil</!
 Ylk<kqzqVf<K!Ylk<kQfQI?!Ylk<jkzl<!wMk<K!upr<gzil</!
!
Ylk<kQfQI< Q Q< Q Q< Q Q !
! 2551!gq!Ylk<kqz<!9511lq/zq!k{<{QI!uqm<M!uijzbqz<!ucg<g!d{<miuK!
Ylk<kQfQI/! -keiz<! Dpq?! ubqx<Xh<ohiVlz<?! ubqx<Xuzq?! osiqbig<! gpqs<sz<?!
lf<kl<!-jugjth<!Ohig<Gl</!!ngm<Muib<!ngx<xq!osb<jg!-kx<G{<M/!
!
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Ylk<jkzl<< << << <!
! kQfQiqe<!lQK!lqkf<K!hcBl<!w{<o{b<!Ylk<jkzoleh<hMl</!
! 2.4!Ktq!ujv!Ylk<jkzl<!Ofib<gTg<G!kvzil</!
. G{himl<!&zqjg!
Yll<!OsVl<!hqx!lVf<Kgt<< < < << < < << < < <;!
2/!kqh<hqzqbikqs<!$v{l<< < << < << < <!
nEhiel<! ! ;!! Oke<!
kQVl<!Ofib<gt<! ;!! dt<!&zl<?!nm<mGe<ll<?!uib<U/!
. wtqb!juk<kqb!Ljxgt<!911!
3/kqiqgMgikq!$v{l<<<<!
ntU!! ! ;!! ouVgc!)yV!sqm<cjg!ntU*!
kQVl<!Ofib<gt<! ;!! lf<kl<?!sk<kq?!nOvisgl<!
. wtqb!juk<kqbLjxgt<!911/!
4/!nsQv{k<kqx<G!GcfQIQ < < QQ < < QQ < < Q !
kQVl<Ofib<!! ! ;! nsQv{l<!
. wtqb!juk<kqb!Ljxgt<!911!
5/!NX!nkqsivk<Kg<Gl<!GcfQI< < < Q< < < Q< < < Q !
kQVl<!Ofib<gt<!! ;! si<u!nkqsivr<gt<!
. wtqb!juk<kqb!Ljxgt<!911!
6/!Yl!Ozgqbl<<<<!
ntU!! ! ;! 8!lR<sic!)2931!lq/gqvil<*!
kQVl<!Ofib<gt<!! ;!! w{<ujg!Ge<ll<?!&zuiB!nkqsivl<?!!
ohiVlz<?!osiqbijl?!Htqk<Okh<hl</!
. wtqb!juk<kqb!Ljxgt<!911!
!
! !
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4/!likjtYM!
! likjtYM! Kui<h<hq! osb<jgjbBl<! hsqk<kQk<K~{<c! osb<jgjbBl<!
ogi{<Mt<tK/!
  “uif<kqhqk<k!OkimoliM!lixig<!gMh<hezR<!
! Osi<f<Kfqe<x!&zvk<kf<!kQIg<Gr<gi{<!.!lif<ktqi<g<jg!
! liOk! bqsk<kH]<c!uz<zhue<!d{<miGl<!
! H,kzk<Kt<!liKjtbqe<H,”!
. ngk<kqbi<!G{uigml<!
!! -keiz<! GVkq! uif<kq?! ubqx<Xg<gMh<H?! ouh<hl<?! GVkq! &zl<! -ju!
OhiGl</!!-K!GVkqjbh<!ohVg<Gl<!ue<jljbk<!kVl</!
“liKjt!geqB{!lkegi!OlSvf<!
$oke!uiBei<!osiz<Zui<!lqg<gOu”!
!! liKtl<! ! hpk<jkk<! kqeLl<! Hsqk<Kuiqe<! N{<jlh<ohVg<G! Lkzqbe!
d{<miGl</!
! -h<hpk<kqeiz<!Lh<hq{q!Svk<kqz<!gi{<gqe<x!uif<kq?!fQI!Oum<jg!-jugt<!
Ohil</!!hqt<jt!d{<migilx<!osb<gqe<x!$zOfijbh<!Ohig<Gl</!!uib<fQI!Dxz<?!
uqg<gz<?! lf<kl<?! ouh<hk<kiz<! d{<mie! gib<s<sz<?! ofR<osiqU?! gikjmh<H?!
lbg<gl<!-juOhil</!
! “ouck<KuQp<!hpk<jk!uir<gq!olz<zqb!sQjz!gm<c!
! gMogeh<!hqpqf<K!ogi{<M!g{<msi<g<g!gjvBr<%m<c!
! Gck<kqm!ouch<H!liXr<!Gtqi<f<kqMl<!nr<golz<zil<!
! uck<kkfe<!olipqbq!eiOt! liKtl<!hpk<kqe<siOx”!
. Okve<!G{uigml</!
likjtbqe<!ohiK<<< !lVk<Kuh<hbe<< < << < << < <!
 H,olig<jg!dzi<k<kqh<!ohick<K!241lqgq!ogiMg<g!-Vlz<!fQr<Gl</!
 hpk<Okiz<! ohic! 28! gqvil<?! out<jth<Ohitl<! 28gq?! sQjls<!
S{<{il<Hk<K~t<!45!gqvil<!Osi<k<Kg<!gzf<K!hz<!Kzg<g!hz<uzq!OhiGl</!
 hpk<OkiZme<! sqxqK! -zur<gl<?! -zur<gh<! hm<jm! fSg<gqh<Ohim<M!
Ljxh<hc! GcfQiqm<M! 26.41lqzq! uQkl<! kqel<! 4.5! Oujt! ogiMk<K! uv!
fim<hm<m!sQkg<gpqs<sz<!fQr<Gl</!
 hpk<Okiz<?! lr<G^<kie<! hpk<Okiz<?! ljzlvh<hm<jm! ujgg<G! 51! gqvil<!
wMk<K?! 2511! lq/zq! fQI! uqm<M! Ljxh<hc! GcfQiqm<M! 26.41! lqzq!
ogiMg<gzil</!
 liKjth<! hqR<S! GcfQiqm<M! sQkOhkq?! nkqsivl<! LkzqbjugTg<G!
ogiMh<hK!fim<M!upg<gl</!
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 H,ju!dzi<k<kq!$v{qk<K!nkqz<! 5!gqvil<!wMk<K!Ouzl<!hqsqe<!K~t<! 5!
gqvil<?! nhqe<! 2:6! lqgq! OsIk<K! Oujtg<G! 371.4:1! uQkl<! ogiMk<Kuv!
sQkg<gpqs<sz<?!GVkq!gpqs<sz<!Ngqbju!fQr<Gl</!
 hps<six<jx!-jth<H!Ofibqei<g<G!ogiMg<g!fe<jlk<kVl</!
–!G{himl<!&zqjg!
likjt!YM!OsVl<!hqx!lVf<Kgt<< < << < << < <;!
!
2/!sIu!Svr<gTg<Gl<!nkqsivk<kqx<Gl<!GcfQi<< < < < < < Q << < < < < < Q << < < < < < Q <!
kQVl<!Ofib<gt<!! ;!! si<u!Svr<gt<?!nkqsivl<!
3/!NX!nkqsivk<Kg<Gl<!GcfQI< < < Q< < < Q< < < Q !
kQVl<!Ofib<gt<!! ;!! si<u!nkqsivr<gt<!
. wtqb!juk<kqb!Ljxgt<!911!
4/!&z!fquiv{!Ozgqbl<<<<!
kQVl<!Ofib<gt<! ;!! -vk<k!&zl<?!sQp<&zl<?!Nseg<!gMh<H?!!
! ! ! ! &zg<gqvi{q!
. sqgqs<sivf<kQhl<!juk<kqb!sqf<kil{q!
!
! !
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5/!gxqOuh<hqjz<<< !
!
!! gxqOuh<hqjz! hsqk<kQk<K~{<c! lx<Xl<! dvlig<gq! osb<jgjbg<!
ogi{<Mt<tK/!
! “uibqeVsq!ubqx<Xjts<s!eQMSvl<!
hiBgqe<x!hqk<kLole<!h{<[r<gie<!.!K~b!
lVOuX!gif<ktr<jg!liOk! dzgqx<! !
gVOuh<!hqjzbVf<kqg<!gi{</” 
. ngk<kqbi<!G{uigml<!
!! gVOuh<hqjzbiz<?! Sjubqe<jl?! sQkOhkqbiz<! uVl<! ubqx<XjtU?!
hpR<Svl<?!hbqk<kqbl<!Ngqb!-ju!fQr<Gl</!
!
gxqOuh<hqjzbqe<!ohiK!lVk<Kuh<hbe<gt<< < < < < << < < < < << < < < < <!
 gxqOuh<hqjz! -jzjb! fqpzqZzi<k<kq! -kEme<! lqtG?! dh<H?! sQvgl<?!
Sg<G!Lkzqbux<jx! ohicbig<gq! Osix<xqz<! %m<c?! ogiR<sl<! ofb<! uqm<M!
gzf<K!d{<{!lf<kl<?!lf<kOhkq?!lzOkiml<?!lzg<gm<M!fQr<Gl</!
 gxqOuh<hqjz!-jzBme<!uXk<k!dh<H?!uXk<k!lqtgib<!%m<c!Kjubz<!
osb<K! Ngivk<Kme<! ! sih<hqm! nOvisgl<?! nkqsivl<?! hqk<kuif<kq?!
osiqbijl!-jugt<!fQr<Gl</!
 =Ig<gqe<!Hx{qjb!Ljzh<hizqm<M!-ck<K!-vsl<!hqpqf<K?!gqvil<H?!kqh<hqzq!
Osi<k<K!3?!4!kvl<!Gpf<jkgm<Gh<!Hgm<m!uif<kq!fqx<Gl</!
 -ke<! =Ig<Gme<! Oui<h<hQIg<G?! ofz<zqbQIg<G! Osi<k<K! -ck<K! fQIuqm<M!
gib<s<sq!ogiMg<g!dmOe!uif<kq!fqx<Gl</!
 -ke<! -jzBme<! 2?! 4! lqtG! Osi<k<K! ofb<bqz<! uXk<K! ouf<fQI! uqm<M!
njvk<K! gjvk<K! hizi<gTg<G! fQvim<cb! hqe<! Gch<hqg<g! lf<kl<! fQr<gq!
hsqjb!d{<M!h{<[l</!
 niqsqBme<! -jzjb! Osi<k<K! dvzqzqm<M! Gk<kqk<! Okb<k<Kh<! Hjmk<K!
uqm<M?!-u<uiqsqBme<!yV!hPk<Kzi<f<k!lqtgib<!%m<c!gVg<gq?!sif<k!fqxl<!
uVl<! hg<Guk<kqz<! usl<H! sil<hz<?! sqXfigh<H,?! nkquqmbl<! -jugt<!
Osi<k<K!fQI!uqm<M!S{<mg<gib<s<sqg<!ogiMg<g?!nsQv{Ohkq!fQr<Gl</!
.!G{himl<!&zqjg!!
G{l<<<<!
! Olgl<!nez<oum<jmSvl<!uQEhqk<k!Lf<okijzBl<!!
OhigLXl<!olb<lVf<Kl<!ohib<lVf<kil<!.!hiGolipq!
liOe!gxqh<hijt!le<El<-jz!jbk<kqeLf<!
kiOe!bVf<Kui<g<Gf<!kie</!
. hkiIk<k!G{sqf<kil{q!
Olgl<?!nez<?!Svl<?!hqk<kl<!Ohigl<!d{<mil</!
! !
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6/!S{<jmux<xz<< < << < << < <!
!
! S{<jmg<gib<! jgh<H! Sjujbg<! ogi{<M! dt<tK/! ! Ogijpbgx<xq?!
Fm<HPg<ogiz<zq!lx<Xl<!hsqk<kQk<K~{<c!osb<jgjbg<!ogi{<Mt<tK/!
!
! S{<jmbqe<!gib<lf<!KjxBm!ebqe<xqm!
! l{<cb!hbqk<kqb!uzqobzi!lgZOl/!
. Okve<!gih<hqbl<!
. !
S{<jmg<gib<! ux<xjzh<! Hsqk<Kuiqe<! kQg<Gx<xk<kqZ{<mie! Wh<hl<?!
ubqX~kz<?!ubqx<Xuzq!Lkzqbe!Ohil</!
!
! hqk<kn!Ovisgl<Ohil<!Ohvih<!HPs<siGl<!
! dx<x!gqvi{qbXl<!dm<hsqbif<!!.!sk<kqblib<h<!
h{<jmg<!GkNll<!hx<Xlqr<gq!bijvBf<kie<!
S{<jmg<gib<!ux<xZ{<{s<!osiz</!
. hkiIk<k! G{! sqf<kil{q! &zLl<!
djvBl<!
S{<jmux<xzqe<!ohiK!lVk<Kuh<hbe<!< < < < < << < < < < << < < < < < !
 S{<jmux<xz<?!gVOuh<hqjz?!lir<ogim<jmh<!hVh<H?!Yll<?!ofz<zqLt<tq?!
liKjt! YM?! ouf<kbl<! Ngqbju! keqk<keqOb! -tuXh<hig! uXk<K!
$v{R<! osb<K! %m<c! &e<X! sqm<cjgjb! gijz! lijz! Oliiqz<!
-VOujt!kv!osiqbig<gpqs<sz<?!&zl<!fQr<Gl</!
 S{<mg<gijb!sqx<xil{g<og{<o{b<!uq<m<M!uXk<K!dh<H?!lqtG?!sQvgl<?!
gxqOuh<hqjz?! ouf<kbl<! Ngqbux<jx! uXk<Kg<! %m<ch<! ohick<K!
Osix<Xme<!gzf<K!d{<{!&zl<?!lf<kl<!fQr<Gl</!
 S{<jmOui<?! Kl<jhOui<?! -Zh<jhh<! hq{<{ig<G! -l<&e<Xl<! YI! wjm!
wMk<Kh<!ohicosb<K!Lgv!Lh<hq{q!fQr<Gl</!
 Oui<h<hm<jmjbh<!ohic!osb<K!Okr<gib<g<!GMg<jgbqz<!jug<g!Ou{<Ml</!!
-kje! yV! sqm<cjg! &g<gqzqPg<g! kjzOfib<?! fQOvx<xl<?!
l{<jmg<Gjms<sz<?!yx<jxk<kjzuzq?!&g<gqz<!fQI!hib<kz<!-juOhil</!
 Lh<hq{qg<Gl<?! &s<Sk<! kMlix<xk<kqx<Gl<! osb<Bl<! &g<Gh<ohic! -ux<xqx<G!
-e<xqjlbik!svg<G!NGl</!
! !
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S{<jmux<xz<!OsVl<!hqx!lVf<Kgt<< < < < < << < < < < << < < < < <!
2/!S{<jm<<< ux<xz<!$v{l<< < << < << < <!
!! nEhiel<!! ! ;!! wVjlk<kbqi<!
kQVl<!Ofib<gt<!! ;! lf<kl<?!-jvs<sz<?!&zl<?!gpqs<sz<?!!
gqvg{q!kQVl</!
.!sqk<k!juk<kqb!kqvm<M!
! !
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7/!lir<ogim<jmh<hVh<H< < < << < < << < < < !
! lir<ogim<jmh<!hVh<H!HPg<ogiz<zq?!Kui<h<hq?!dt<tpzix<xq?!dmZvlig<gq!
Ngqb!osb<jggjtg<!ogi{<Mt<tK/!!-ju!gpqs<sZg<G!lqg!sqxf<kK/!!-ju!
Kui<h<H!Sjujbg<!ogi{<Mt<tK/!
! “kiKfm<ml<!uikf<!keqg<gqvf<kq!bil<hqsqOhir<!
! giKLm<mh<!hg<GuqMr<!giblkqz<!.!YKgqe<x!
! hir<gixih<!H{<utVl<!hx<%sr<!osix<GtXl<!
! lir<giB{<!hijv!lE/”!
.!ngk<kqbi<!G{uigml<!
“$kfx<!gib<geq!Kb<k<kqm!U{<olzq!
OukLx<!xjuobzi!lqjlh<hqeq!ozipqBOl”!
.!Okve<!gih<hqbl<!
lir<gib<?! lil<hpl<! -jugjt! Ljxh<hc! Hsqk<kiz<! lek<kti<s<sq?!
ue<jlg<GjxU!ypqBl</!
!
lir<ogim<jmh<!hVh<hqe<!lVk<Kuh<hbe<gt<< < < < < < < < << < < < < < < < << < < < < < < < <!
 gpqs<sz<!Ofib<gTg<G!yV!fe<lVf<kiGl</!
 fim<hm<m!sQkg<gpqs<sZg<G!lil<hVh<Hme<!nhqe<!%m<cg<!ogiMk<kiz<!lqGf<k!
fe<jl!kVl</!
 keq! lil<hVh<jh!lik<kqvl<!K~t<! osb<K! 4!gqvil<!Lkz<! 7! gqvil<! wjm!
ogiMg<gzil</!
 hVh<jh!wMk<Kh<! ohie<eqxlig!uXk<K!K~t<!osb<K! 436.761!lqgq! wjm!
ujv! ogiMg<g! ubqx<Xg<gMh<H?! sQkg<gpqs<sz<?! GVkqg<gpqs<sz<! Ngqb!
-juh<Ohil</!
 lir<ogim<jmh<! hVh<H?! gsgsi?! Sg<G?! Yll<! YI! wjm! wMk<Kh<!
hps<six<xizjvk<K! nkqz<! yV! sqm<cjgjb! ofb<bqz<! Gph<hqg<! ogiMg<g!
ohVr<gpqs<sz<!kQVl</!
 lil<hVh<jh!sqX!K{<Mgtig!fXg<gq!oub<bqzqz<!dzi<k<kqh<!ohic!osb<k!
K~t<! 283! gqvil<! Sg<G?! lqtG?! sQvgl<! -jugtqe<! K~t<! ujgg<G! 53!
gqvil<?!lil<hqsqe<!K~t<!31!gq?!nhqe<!5!gq!-ux<jx!fe<xig!njvk<K!4.6!
Ge<xqujv!kv!gpqs<sz<!Ofib<gt<!kQVl</!
 wz<ziujg!gpqs<sz<!Ofib<gTg<Gl<!sqxf<kK/!
!
!
!
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!
-jz?!H,!lVk<Kuh<!hbe<gt<< < < << < < << < < <!
!
 -jzjbh<!hqpqf<okMk<k!siX!4!Okizi?!Oke<!yV!Okizi?!hiz<!yV!
Okizi?!hS!ofb<!½!Okizi!ye<xib<g<!gzf<K!GVkqg<!gpqs<sZg<Gg<!
ogiMg<gzil</!
 -jzjb! Sm<Ms<! sil<hzig<gq! ou{<o{bqz<! Gjpk<K! kmu! kQh<H{<!
Oug<giM!Ngqbju!OhiGl</!
 H,ju! dzi<k<kqg<! GcfQiqm<M?! gpqs<sz<?! fim<hm<m! sQkg<gpqs<sz<!
LkzqbjugTg<G!ogiMk<K!uvh<!OhiGl</!
 H,ju!dzi<k<kqh<!ohicjb!Hjguqm!ogiSg<gt<!YcuqMl</!
!
lilv!OuIh<hm<jmbqe<!lVk<Kuh<hbe<gt<< < < < < < << < < < < < << < < < < < <!
-keiz<!sQkg<gpqs<sz<?!ubqx<Xg<gMh<H?!uif<kq!-jugt<!OhiGl</!
!
lir<ogim<jm!G{l<< < << < << < <!
! -ke<! hVh<hqeiz<! sQkg<gpqs<sz<?! GVkqg<gpqs<sz<?! ohVl<hiM! Ngqbju!
fQr<Gl</!
! OhSOl!sQkh<!ohVg<GR<Osv!iqg<gMh<Hl<!
! uQSOli!&zLX!our<ogikqh<H!–!liSjmb!
! H,r<ogim<jm!jbk<kt<tqh<!Ohim<Mg<!geqbqz<uf<k!
! lir<ogim<jmjbg<!gi{qz<!uviK/!
. hkiIk<k!G{sqf<kil{q!&zLl<!djvBl<!
!
lir<ogim<jmh<!< < << < << < < hVh<H!OsVl<!hqx!lVf<Kgt<< < < << < < << < < <!
2/!S{<jmux<xz<!$v{l<< < < << < < << < < <!
kQVl<!Ofib<gt<! ;!! &zl<?!gqvi{q?!gpqs<sz<!
. sqgqs<sivf<kQhl<!juk<kqb!sqf<kil{q!
! !
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8/!ouf<kbl<< << << <!
ouf<kbl<! jgh<H! Sjujbg<! ogi{<Mt<tK/! OlZl<! -ju!
sqXfQIh<ohVg<gq?! dt<tpzix<xq?! Kui<h<hq?! gill<ohVg<gq?! ngm<Muib<ugx<xq!
osb<jggjtg<!ogi{<Mt<tK/!
hqk<kUkq!vl<OhiGl<!Ohvig<!g{r<gTl<Ohil<!
nk<kqSvf<!kigl<!ngZr<gi{<!.!kk<Klkq!
Oug!-VloziM!uQX!gbl<k{qBl<!
OhigLXl<!ouf<kbk<jkh<!Ohix<X!
. hkiIk<kG{!sqf<kil{q!&zLl<!djvBl<!
!
ouf<kbl<!Okijsbib<!Ou{<c!B{<!cmUmz<!
! jlf<Kme<!hVk<kqMl<!uzqgjt!obipqk<kqMr<!!
! gVj{bq!z0kqj{g<!gzf<kbqe<!kqmUm!
! Zvoleh<!hVk<kqm!L{<jlbq!kigOu/!
. Okve<!gih<hqbl<!
ouf<kbk<kqe<!lVk<kuh<!hbe<gt<< < < < < < << < < < < < << < < < < < <!
 ouf<kbk<jk! uXk<Kh<! ohic! osb<K! Dxz<! fQI! osb<K! dm<ogit<t!
ubqx<Xuzq?! ubqx<Xh<! ohiVlz<?! Svl<?! dm<$M?! out<jt! sQkg<gpqs<sz<!
fQr<Gl</!
 ouf<kbl<! 28! gqvil<?! 451! lqgq! hs<siqsqBme<! Osi<k<Kh<! ohir<gq!dh<hqm<Ms<!
sih<hqm!GVkq!ohVGl</!
 gR<sqbqz<!Osi<k<Kg<!gib<s<sqg<!ogiMg<g!hiz<!Svg<Gl</!
 njvk<Kk<! kjzbqzh<hq! Dx! juk<Kk<! kjz! LPgquv! lbqi<! utVl</!!
lbqi<!dkqi<f<K!Ohiujk!kMg<Gl</!
 -jk!liuig<gqg<!gtq!gq{<cg<!gm<m!H{<!H,s<sq!Ohig<Gl</!
 -jk!uXk<K!-k<Kme<!nu<utU!uXk<k!OgiKjljb!%m<c!gih<hqg<G!
hkqzig!upr<gzil</!!-keiz<!dmz<!ouh<hl<!fQr<Gl</!
 lqtgib<?! gMG?! ouf<kbl<?! Kuvl<! hVh<H?! gxqOuh<hqjz?! gibl<!
-jugjtk<! kg<gtU! wMk<K! ofb<! uqm<M!uXk<K?! Htqg<Gpl<jh!-kqz<!
ogim<c?! dh<HOsi<k<Ks<! sm<c! &c?! njvh<higl<! S{<cbhqe<! -xg<gqs<!
$m<Mme<!sih<hqm!ouh<hk<kiz<!OfiqMl<!sqx<sqzh<!hq{qgt<!k{qBl</!
 ouf<kbl<?! gMG?! ohVr<gibl<?! gxqlR<st<! -jugjts<! slhigl<! wMk<K!
ofb<uqm<M! uXk<Kh<! ohic! osb<K! Osix<Xme<! gzf<K{<{! ubqx<Xuzq?!
ohiVlz<?!uzh<him<M! .!-mh<him<Cvz<!uQg<gr<gt<!fiTg<G!fit<!Gjxf<K!
ogi{<M!uVl</!
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3.2. MODERN ASPECT  
 
1. MURRAYA KOENIGII 
BOTANICAL ASPECT 
 According to Bentham and hooker Genera – plantarem murraga koenigi is 
classified under 
Class : Dicotyledons 
Order : Sapindales 
Family : Rutaceae 
Genus : Murraya 
Species: Koenigii 
 
Habit and Habituate 
 From Garhwal to sikkim, Bengal and southward to Travancore. 
 It is a small tree upto 5m tall with attractive habit. 
 
Part used 
 Bark, Root and Leaves. 
 
Murraya koeinigii 
 The plant is propagated from seeds and can be slown directly in the pit or 
seedings transplanted. 
 Pits are 60cm depth and diameter and filled with compost.  The plant live upto 
30 years and go on producing aromatic  leaves throughout the year. 
 
Actions 
 The leaves – bark and the roots possess carminative, tonic and stomachic 
properties. 
 
Parts used 
 Bark, Root and Leaves 
 
Phytochemistry of Murraya koeinigii 
Leaves 
 It contain a volatile essential oil, resembling the oil of Aegle marmelos, a resin 
and a crystalling principle glucoside named koenigin. 
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 The leaves are aromatic and contain protein, carbohydrate, fiber, minerals, 
carotene, nicotinic acid and vitamin C.  It is rich in vitamin A and calcium.  The 
leaves contain very high amount of oxalic acid.  The leaves yield essential oil 0.04%, 
bright yellow in colour.   
Bark 
 Synthesis of murrayanine, m.p 168° from Bark. 
Fruits 
 Koenimbine, m.p 194° and konigcine are present in fruits. 
Stem bark 
 A carbazole carboxylic acid – mukoeic acid m.p. 242° are present in stem 
bark. 
Preparations 
 Infusion and decoction 
Uses 
 Green tender leaves are eaten raw the cure of dysentery,  Decoction of the 
leaves are given as a febrifuge in fever.  Leaves are popularly used for flavouring 
curries and condiments. 
- Medicinal herbs with their formulation – 
vol-2 
- Handbook of medicinal plants 
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2. PUNICA GRANATUM 
Modern aspect of pomegranate 
Classification 
Kingdom :  Plantae 
Class  : Magnoliophyta 
Order  : Myrtales 
Family  : Punicaceae 
Genus  : Punica 
Species : Granatum 
 
Habit and Habituate 
 It is a deciduous small tree, may attain a maximum height of 8 cm with 
reddish scarlet flowers.  The fruit contains large number of hard seeds covered with a 
juicy red, pink or yellowish white, sweet astringent acid pulp. 
 The species is orginated in persia, Afganistan and Balchistan.  It is also found 
wild in the warm valleys of Himalayas. 
 
Parts used 
 Flowers, rind of this fruit, fresh fruit juice and dried bark of the stem and root. 
 
Action 
 Astringent and Anthelmintic. 
 
Phytochemistry 
 Bark of  trunk or roots possess medicinal properties which contains 20 to 22% 
tannin : 0.5 to 1% alkaloids. 
 The seeds contain steroidal estrogens.  The fruit pulp contain proteins, fat, 
fibre, minerals, oxalic acid, carbohydrate vitamins A, B and C. 
 Root bark contains punico tannic acid 20 to 25 p.c mannite, sugar, gum pectin, 
ash 15 p.c, an active liquid alkaloid pelletierine and oil  liquid “isopelletieribe”  and 
two inactive alkaloids methylpelletierine and pseudo-pelletierine. 
 Punico-tannic acid when boiled with dilute sulphuric acid is resolvable into 
illogic acid and sugar. 
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Uses 
 Bark of this plant is anthelmintic and for expelling tapeworm is said to be very 
effective. 
 The bark and the rind of the fruits and seeds are commonly used in dysentry 
and diarrhoea. 
 Leprosy patients get benefit from fruit juice. 
 The flowers yield red dye which is used for dyeing cloth. 
- Medicinal herbs with their formulations – 
vol-2 
- Handbook of medicinal plants. 
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3.TRIGONELLA FOENUM-GRAECUM 
 
Modern aspect of Fenugreek seed 
Class  : Dicotyledons 
Subclass : Rosidae 
Order  : Fabales 
Family  : Fabaceae 
Genus  : Trigonella 
Species : Foenum-graecum 
 
Habit and Habituate 
 It is a hardy annual plant leaves are feather shaped.  Flowers are whitish in 
colour. 
 The species is native to Eastern Europe and Ethiopia.  It grows wild in parts of 
North India. 
 
Botanical description 
 An annual herb with an erect prostate, smooth, little branched stem and 
trifoliate leaves, the leaflets oblanceolate to oblong and slightly toothed. 
 The unstalked yellowish-white, violet-tinged flowers are solitary or in pairs in 
the upper leaf axils.  The fruit is a hairless slender, slightly curved pod with an 
extended tip. 
 
Parts used 
 Seeds, pods and leaves. 
 
Action 
 Astringent, resolvent, emollient. 
 
Phytochemistry of trigonella foenum – graceum 
Constituents 
 A glycoside of furost-5-en 58,22,26- triol with glucose and xylose as sugars 
isolated from seeds.  Saponins –grae urins A, B, C,D, E, F and G-isolated  from 
leaves. 
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Diosgenin content of seeds from India was 0.78-1.9%, maximum amount (2.03%) in 
cotyledons; germination increased diosgenin content by 9.0%; germination in 
presence of yeast extract and cholesterol increased diosgenin content by 25.5%. 
 The vegetative parts are rich in vitamin A, B and iron. 
 
Uses 
 The decoction of seeds as administered in drinks, rectal injections and lotions. 
 The seed is also used to resolve inflammatory tumours, such as carbuncles, 
phylegmons  and whitlows.  The flower is recommended for chapping, haemorrhoidal 
tumours, in rectal injection, for dysentery, diarrhoea, bilious and inflammatory colics. 
- Handbook of Medicinal uses 
- Medicinal plants and their 
formulations 
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4. MANGIFERA INDICA 
Modern aspects of Mango 
Classification 
Kingdom : Plantae 
Order  : Sapindales 
Family  : Anacardiaceae 
Genus  : Mangifera 
Species : Indica 
 
Habitat 
 This tree indigenous to India and cultivated in many varieties almost 
everywhere in gardens. 
 
Parts used 
 Fruit, kernel, leaves, flowers, bark and gum. 
 
Botanical description 
 It is a large tree with tap root system.  The tree is spreading evergreen with a 
dense rounded or globular crown. 
 Leaves are simple, alternate, irregularly placed along the branchlets. 
 
Phytochemistry 
 The fruit is a rich source of vitamin A and C apart from minerals and other 
vitamins.  The ripe fruit contain nearly 20% total soluble sugar 0.2-0.5% acid and 1% 
protein. 
 The kernel contain 9.5% protein mango seed oil is extracted from mango 
kernels. 
 Mangiferin, amino acids, gallotannin, gallic acids, ethylgallate, isoquercetin, 
quercetin and β – sitosterol present in various parts of the plant. 
 Citronellar, diferpene, geranio, limonene, mangiferol, mangiterone, nerol, 
nerylacetate, α and β – pinene and tanin present in panicles and leaves. 
 
Pharmacological activities 
 Antibacterial, antifungal, CNS and Cardio stimulant, cardiotonic, anti-
influenza virus activity. 
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Action 
 Fruit is laxative, diuretic, diaphoretic, astringent, refrigerant. 
 Unripe fruit is acid, astringent, stomachic. 
 Bark is astringent and tonic. 
 
Preparations 
 Sherbats, custards, preserves, confections, pickles, curries and chutneys. 
 
Uses 
 The bark is astringent, it is use of in diptheria and Rheumatism.  It possesses a 
tonic action on the mucous membrane. 
 The kernel juice is snuffed once a day for three days to stop nasal bleeding. 
 The unripe mango is useful in opthalmia and eruptions. 
 The rind is astringent, stimulating tonic in debility of stomach. 
 Mango and its preparations are used for several urinary purposes. 
- Handbook of medicinal plants 
- Database on Medicinal plants used in 
Ayurveda 
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5. PHYLLANTHUS EMBLICA 
Classification 
Kingdom : Plantae 
Order  : Malpighiales 
Family  : Phyllanthaceae 
Genus  : Phyllanthus 
Species : P.emblica 
 
Botanical description 
 Deciduous tree with the ultimate branches phyllanthoid.  Leaves are simple, 
many in each branch set, small, linear-oblong, 15x3mm, entire; flowers unisexual, 
greenish yellow in dense axillary fasicles along the branchlets; tepals 6 oblarceslate; 
in male flowers stamens 3 filaments connate to form a short column; 
 In females ovary globase, 3-chambered with 2 ovules in each; fruit depressed 
globase, fleshy, 3cm across, shining yellowish green when ripe; seeds trigonous. 
 
Habitat 
 The plant is found both in the wild and cultivated state throughout tropical 
India.  Also distributed in North burma, south china, Indo china and Malaysia. 
 
Action 
 Astringent, laxative, diuretic, bitter, tonic. 
 
Chemical constituents 
 Vitamin C, this is one of the major ingredients of the famous tonic 
cyavaraprasam and can also help improve intelligence and memory power. 
 The major amino acids present are alarine, aspartic acid, glutamic acid, lysine 
and proline. 
 The fruit contains chromium and copper. 
 
Parts used 
 Root, bark, leaves and fruits. 
 
Uses 
 It acres diseases due to morbid Vatha, Pitha and Kapha and is especially good 
for the abundant growth of hair. 
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 The drug which cures thirst, burning sensation, vomiting, diabetes, emaciation, 
anorexia, toxicocis, fever, impurity of blood and haemorrhage. 
 It is useful in cough, dyspnoea, inflammation of eyes, jaundice, leukorrhoea 
and menorrhagia. 
 The ripe fruit is forms an ingredient of preparation like triphaladi tailam, 
mahatiktaka ghrtam, kayyanyadi tailam. 
- Medicinal plants and their 
formulations 
- Medicinal plants –
Moshrafuddin ahmed. 
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6. SOLANUM TORVUM 
Classification 
Kingdom - Plantae 
Order  - Solanales 
Family  - Solanaceae 
Genus  - Solanum 
Species - S.torvum 
 
Botanical description 
  A shrub up to 4m high, pubescent, leaves ovate, sorrate or cobed, shortly 
accuminate, membraneous, sparsely stellate, pubscent, above, more closely so beneath 
base unequal or  rounded; flowers white usually extra-axillary, often branched, 
anarmes cymes, pedicels slender;  fruit pubescent outside, lobes spreading, linear, 
oblong or lanceolate, berry globose, seated on a persistence calyx . 
 
Flowering and fruiting 
 September – October 
 
Distribution 
 Assam, Khasi and Jaintia hills of Meghalaya. 
 
Propagation 
 By seeds 
 
Parts used 
 Leaves and fruits 
 
Uses 
 Leaf is useful for wounds and fruit is used as a cure for cough. 
 
- Medicinal plants (Moshrafuddin ahmed) 
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7. TRACYSPERMUM AMMI 
Classification 
Kingdom - Plantae 
Order  - Apiales 
Family  - Apiaceae 
Genus  - Trachyspermum 
Species - T. ammi 
 
Description 
 Ajwain small, oral shaped, seed like fruits are pale brown schizocarps, which 
resemble the seeds of other plants in the apiaceae family such as caraway, cumin and 
fennel.  They have a bitter and pungent taste.  They smell almost exactly like thyme 
because they also contain thymol.  But they are more aromatic and less subtle in taste, 
as well as being somewhat bitter and pungent. 
 
Cultivation and production 
 The plant is mainly cultivated in Iran and India. 
 
Culinary uses 
 The fruits are rarely eaten raw.  They are commonly dry-roasted or fried in 
ghee.  This allows the spice to develop a more subtle and complex aroma. In Indian 
cuisine, it is often part of a chaunk, a mixture of spices fried in oil or butter, which is 
used to flavor lentil dishes. 
 It is widely used in pakistani cusine as well and it is also an important 
ingredient for herbal medicine practical there. 
 
Uses in traditional medicine 
 Ajwain is used in traditional Ayurveda primarily for stomach disorders such as 
indigestion, bloating, fatigue, abdominal pain, flatulence, diarrhoea and colic along 
with respiratory distress and loss of appetite. 
 In Siddha medicine, the crushed fruits are applied externally.  
      https://en.m.w ikipedia.org>wiki>Ajwain 
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ANUPANAM 
HONEY 
 Honey is a naturally converted form of sugary food, the nectar of flowers and 
other plant exudations systemically collected and stored by honey bees. 
Honey as a vehicle: 
Physical properties of honey 
Aroma   : Depends upon the floral source from  
where it’s collected. 
Colour   : It ranges from pale yellow or yellowish brown  
to dark brown. 
Specific rotation :  +3 to -10 
Constituents of honey 
 Honey contains chiefly dextrose and fructose moisture, small amounts of 
sucrose and mineral constituents. 
 Moisture: 20.6% fructose: 38%  glucose : 31% sucrose: 1% other sugar 
8.5% fat: 0.1% minerals: 0.2% , Protein 0.3%  others: 0.4%. 
 Vitamins present in honey are vitamin B1-B6, Vitamin C. 
 Minerals include calcium, phosphorous and Iron. 
 Trace elements in honey arte magnesium, selenium, sulphur, chloride and 
silica. 
 Coloring matter: Caroline, chlorophyll, xanthophylls, anthocyanin, tanin.  
 Acids: Acetic acid, formic acid, malic acid, citric acid, succinic acid, 
oxalic acid. 
 Enzymes: Chief enzyme present in honey is invertase.  Other include 
protease, oxidases, peroxidase, reductase. 
      -The wealth of India Vol. II Pg.91) 
Action 
 Antimicrobial 
 Antiseptic 
 Sedative 
 Demulcent 
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Uses of Honey 
 Provides wholesome nourishment also an energy giving rich food. 
 The predigested sugars present in honey are easy to digest and are readily 
absorbed and assimilated by the body. 
 Extensively used in preparing breads, cakes, biscuits, pastries, chewing gums, 
candies. 
 Honey constitutes all important ingredients of certain lotions, cosmetics, 
soaps, creams, balms, inhalations. 
 
Distinguishing quality honey 
 High quality natural honey can be distinguished its fragrance and taste.  The 
honey should  not lay down in layers.  It this is a case, it indicates the excessive 
humidity (over 20%) of the product, and such a honey would not be suitable for long 
term preservation. 
 A fluffy thin layer on the surface of the honey (like a white foam) or marble-
coloured and white spots in crystallized honey at the wall sides of the bottle are 
caused by filling of liquid honey with subsequent sealing- the air bubbles are 
surfacing and part of them is concentrated at the wall sides.  This is an indication of a 
high quality honey, which was tilled without pasteurization (heating). 
 A true  honey that is at least one month old is usually of demure (not 
translucent) colour. 
 
Preservation of Honey: 
 Because of its unique composition and the complex processing of nectar by 
the bees.!
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INGREDIENTS OF KARUVEPPILAI CHOORANAM 
KARUVEPPILAI 
SUNDAIVATTRAL 
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INGREDIENTS OF KARUVEPPILAI CHOORANAM 
MATHULAI ODU 
MANGOTTAI PARUPPU 
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INGREDIENTS OF KARUVEPPILAI CHOORANAM 
Purification process of Poonagam 
Purified Poonagam 
 
IN REDIENTS F ARUVEPPILAI C RANA  
VENDHAYAM 
OMAM 
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INGREDIENTS OF KARUVEPPILAI CHOORANAM 
NELLI MULLI 
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DRUG : KARUVEPPILAI CHOORANAM 
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4. MATERIALS AND METHODS 
Preparation of KARUVEPPILAI CHOORANAM according to the Anuboga 
Vaidhiya Navaneetham part-VIII Pg.no.121, Edition 1995. 
 
Collection and purification of raw drugs 
Materials required 
 Karuveppilai   - 35gms (1 palam) 
 Sundaivattral  - 35 gms (1 palam) 
Mangkottai parupu - 35gms (1 palam) 
 Omam   - 35 gms (1 palam) 
 Nelli mulli  - 35 gms (1 palam) 
 Mathulai odu  - 35 gms (1 palam) 
 Venthayam  - 35 gms (1 palam) 
 
Method of purification 
 All the above ingredients should be dried in sunlight and taken. 
 
Preparation of medicine 
Ingredients 
 Karuveppilai   - 35gms (1 palam) 
 Sundaivattral  - 35 gms (1 palam) 
Mangkottai parupu - 35gms (1 palam) 
 Omam   - 35 gms (1 palam) 
 Nelli mulli  - 35 gms (1 palam) 
 Mathulai odu  - 35 gms (1 palam) 
 Venthayam  - 35 gms (1 palam) 
 
Method of preparation 
 All the above ingredients should be dried in sunlight grinded well seperately 
and are all mixed and make into fine powder (chooranam) by filtering it with pure 
white cloth(Vasthirakayam). 
   Anuboga vaithya Navaneetham Page No.121, edition 1995. 
Dose of drug  : 1-1 ½ varagan edai (4.16 - 6.24 gms) 
Adjuvant  : Honey 
Indications  : Diarrhoea and indigestion. 
38 
 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
PHYTOCHEMICAL ANALYSIS 
PROCEDURE: 
Quantitative Estimation of carbohydrate 
The total sugar content was estimated by Anthrone method (Roe, 1955). A 
known amount of the sample was taken, ground well with 80% ethanol and was 
centrifuged at 4000 rpm. From the supernatant, 0.5 ml was taken and 5 ml of anthrone 
reagent was added. The tubes were kept in a boiling water bath for 15 min. After that, 
they were kept in a dark room for another 15 minutes. The colour intensity developed 
was read in a spectrophotometer at 650 nm. 
  
Ref: ROE, J. H. (1955), “The determination of sugar in blood and spinal fluid with 
anthrone reagent” Ibid., ill: 335-343. 
 
Quantitative Estimation of flavanoids: (Evans, 1996) 
Total flavonoid content was determined by Aluminium chloride method using 
catechin as a standard. 1ml of test sample and 4 ml of water were added to a 
volumetric flask (10 ml volume). After 5 min 0.3 ml of 5 % Sodium nitrite, 0.3 ml of 
10% Aluminium chloride was added. After 6 min incubation at room temperature, 2 
ml of 1 M Sodium hydroxide was added to the reaction mixture. Immediately the final 
volume was made up to 10 ml with distilled water. The absorbance of the reaction 
mixture was measured at 510 nm against a blank spectrophotometrically. Results were 
expressed as catechin equivalents (mg catechin/g dried extract). 
 
Ref: Devanaboyina N et al., “Preliminary Phytochemical Screening, Quantitative 
Estimation And Evaluation Of Antimicrobial Activity Of Alstoniamacrophylla Stem 
Bark” IJSIT, 2013, 2(1), 31-39 
 
Quantitative Estimation of Saponins: (Evans, 1996) 
Methanolic and water extract was dissolved in 80% methanol, 2ml of Vanilin 
in ethanol was added, mixed well and the 2ml of 72% sulphuric acid solution was 
added, mixed well and heated on a water bath at 600c for 10min, absorbance was 
measured at 544nm against reagent blank. Diosgeninis used as a standard material and 
compared the assay with Diosgenin equivalents. 
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Ref: Devanaboyina N et al., “Preliminary Phytochemical Screening, Quantitative 
Estimation And Evaluation Of Antimicrobial Activity Of Alstoniamacrophylla Stem 
Bark” IJSIT, 2013, 2(1), 31-39 
 
Quantitative Estimation of Tannins: (Robert, E.B. 1971. Agro.J.63, p.511)  
1ml of the extract was mixed with 5ml of vanillin hydrochloride reagent (mix 
equal volumes of 8% HCL in methanol and 4% vanillin in methanol). The mixed was 
allowed to stand for 20mins and measure the absorbance at 500nm. The standard 
graph was plotted for working standard catechin solution (0 to 250µg/µl).  
 
Ref: Robert, EB, "Method for estimation of tannin in grain sorghum ", Agro J , 
vol. 63, 1971,p.511; 10. 
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FOURIER TRANSFORM – INFRA RED SPECTROSCOPY 
PERKIN ELMER – SPECFTRUM ONE 
Introduction 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular  structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy. 
 In IR spectroscopy, the resonance absorption in made possible by the change 
in dipole moment accompanying the vibrational transition. The infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies 
are a kind of fingerprint of the compounds. This property is used for characterization 
organic, inorganic and biological compounds. The band intensities are proportional to 
the concentration of the compound and hence qualitative estimations are possible. The 
IR spectroscopy is carried out by using Fourier transform technique. 
Principle 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction,l electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecurlar and electronic structure of the substance and with intra – and inter 
molecular interactions. 
 FT-IR spectroscopy is used primarily for qualitative and quantitative analysis 
of organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave number is referred to as the finger print 
region. Absorption bands in this region are generally due to intra molecular 
phenomena and are highly specific for each material. The specificity if these bands 
allow computerized data searches to be performed against reference libraries to 
identify a material. 
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Table of Characteristic IR Absorptions 
Frequency, cm-1 Bond Functional group 
3640 - 3610 (s, sh) O-H stretch Free hydroxyl alcohols phenols 
3500 - 3200 (s,b) O-H stretch, H – bonded Alcohols, phenols 
3400 – 3250 (m) N – H stretch Primary, secondary, amines, 
amides 
3300 – 2500 (m) O – H stretch Carboxylic acids 
3330 -  3270 (n, s)  –C (triple bond) C – H : C  - H 
stretch 
Alkynes (terminal) 
3100 – 3000 (s) C – H stretch Aromatics 
3100 – 3000 (m) = C – H stretch Alkenes 
3000 – 2850 (m) C – H stretch Alkenes 
2830 – 2695 (m) H – C = 0; C –H stretch  Aldehydes 
2260 -  2210 (v) C (triple bond) N stretch Nitriles 
2260 – 2100 (w) C (triple bond) C- stretch Alkynes 
1760 – 1665 (s) C = 0 stretch Carbonyls (general) 
1760 – 1690 (s) C = 0 stretch Carboxylic acids 
1750-  1735 (s) C = 0 stretch Esters, saturated aliphatic 
1740 – 1720 (s) C = 0 stretch Aldehydes, saturated aliphatic 
1730 – 1715 (a) C = 0 stretch Alpha, beta – unsaturated esters 
1715 (s) C = 0 stretch Ketones, saturated aliphatic 
1710 – 1665 (s) C = 0 stretch Alpha, beta – unsaturat 
aldehydes, ketones 
1680 – 1640 (m) -C = C - Alkenes 
1650 – 1580 (m) N – H bend Primary amines 
1600 – 1585 (m) C-C stretch (in – ring) Aromatics 
1550 – 1475 (s) N – 0 asymmetric stretch Nitro compounds 
1500 – 1400 (m) C –C stretch (in – ring) Aromatics 
1470 – 1450 (m) N – 0 asymmetric stretch Nitro compounds 
1370 – 1350 (m) C – H bend Alkanes 
1360 – 1290 (m) C – H rock Alkanes 
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1335 – 1250 (s) C – N stretch Aromatic amines 
1320 – 1000 (s) C – 0 stretch Alcohols, carboxylic acids, 
esters, ethers 
1300 – 1150 (m) C – H wag ( - CH2X) Alkyl halides 
1250 – 1020 (m) C – N stretch Aliphatic amines  
1000 – 650 (s) =C – H bend Alkynes 
950 – 910 (m) O – H bend Carboxylic acids 
910 – 665 (s, b) N – H wag Primary, secondary amines 
900 – 675 (s) C – H “oop” Aromatics 
850 – 550 (m) C – CI stretch Alkyl halides 
725 – 720 (m) - C (triple bond) C-H : C- H 
bend 
Alkynes 
690 – 515 (m) C  - Br stretch Alkyl halides 
 
M = medium, w = weak, s=strong, n =  narrow, b = broad, sh = sharp 
 
Sampling techniques: 
 There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. 
 Solid : KBr or Nujol mull method 
 Liquid : CsI / TIBr Cells 
 Gas : Gas Cells 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36KBr Method 
 The Sample was grounded using – an agate mortar and pestle to give a very 
fine powder. 
 The finely powder sample was mixed with about 100 mg dried KBr salt. 
 The mixture was then pressed under hydraulic press using a dye to yield a 
transparent disc (measure about 13 mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed.  
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HR SEM - METHODOLOGY 
 
 
HR SEM-Methodology: 
 An SEM is essentially a high magnification microscope, which used a focused 
scanned collection beam to produce images of the sample, both top-down and, with 
the necessary sample preparation, cross-sections. The primary electron beam interacts 
with the sample in a number of key ways:- 
Primary electrons generate low energy secondary electrons, which tend to emphasize 
the topographic nature of the specimen. 
  Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
  Ionized atoms can relax by electron shell-to-shell transitions. Which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few urn of the sample. 
Sample Preparation: 
 Sample preparation can be minimal or elaborate for SEM analysis depending 
on the nature of the samples and the data required. Minimal preparation includes 
acquisition of a KARUVEPPILAI CHOORANAM that will fit into the SEM 
chamber. And it should be analyzed. 
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BIOCHEMICAL ANALYSIS 
BIOCHEMICAL ANALYSIS OF KARUVEPPILAI CHOORANAM 
 
Preparation of extract: 
  5 gms of the drug was taken in a 250ml clean beaker and 50ml of distilled 
water was added to it.  Then it was boiled welll for about 10minutes.  Then it is 
allowed to cool and filtered in a 100ml volometric flask and made up to 100ml with 
distilled water.  The extract is used for the qualitative analysis. 
 
Qualitative analysis:  
S.No. EXPERIMENTS OBSERVATION INFERENCE 
1. Test for calcium: 
2 ml 0f the above prepared extract 
taken in a clean test tube to this add 
2 ml of 4% ammonium oxalate 
solution. 
Formation of white 
colour  precipitate 
 
presence of 
calcium 
 
2. Test for sulphate: 
2 ml of the extract is added to 5% 
barrium chloride solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
sulphate. 
3. Test for chloride: 
The extract is treated with silver 
nitrate solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
chloride. 
 
4. Test for carbonate: 
The substance is treated with 
concentrated HCL. 
 
Formation of 
effervescence. 
 
presence of 
carbonate. 
5. Test for starch: 
The extract is added with weak 
iodine solution. 
 
Formation of blue 
colour 
 
presence of 
starch. 
6. Test for ferric iron: 
The extract is acidified with glacial 
acetic acid and potassium ferro 
cyanide. 
 
Formation of blue 
colour 
 
presence of 
ferric iron. 
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7. Test for ferrous iron: 
The extract is treated with 
concentrated nitric acid ammonium 
thiocyanide solution. 
 
Appearance of 
blood red colour. 
 
presence of 
ferrous iron 
8. Test for phosphate: 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
 
Formation of yellow 
precipitate 
 
 
presence of 
phosphate. 
 
9. Test for albumin: 
The extract is treated with esbach’s 
reagent. 
 
Formation of yellow 
precipitate 
presence of 
albumin. 
10. Test for tannic acid: 
The extract is treated with ferric 
chloride. 
Formation of blue 
black precipitate. 
presence of 
tannic acid. 
 
11. Test for unsaturation: 
Potassium permanganate solution 
is added to the extract. 
 
It gets decolourised. 
 
Presence of 
unsaturated 
compounds. 
12. Test for the reducing sugar: 
5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
add 8 to 10 drops of the extract and 
again boil it for 2 minutes. 
Colour change 
occurs. 
 
Presence of 
reducing sugar. 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1 %  ninhydrin 
is sprayed over the same and dried 
it well. 
Appearance of 
Violet colour 
 
Presence of 
amino acid. 
 
14. Test for zinc: 
The extract is treated with 
potassium  ferro cyanide. 
Formation of white 
precipitate 
Presence of zinc. 
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PRE-CLINICAL STUDIES 
TOXICITY STUDY 
TOXICOLOGICAL STUDIES ON KARUVEPPILAI CHOORANAM 
OBJECTIVES 
 The aim of this study is to evaluate the toxicity of the drug  KARUVEPPILAI 
CHOORANAM, when administered orally to male Wistar Albino Rats with different 
doses, so as to provide a rational base for the evaluation of the toxicological risk to 
man and indicate potential target organs. 
 
Guidelines followed: 
 OECD Guidelines No.423. 
 The experimental protocol was approved by IAEC (Institutional Animal 
Ethical Committee) as per the guidance of CPCSEA (Committee for the Purpose of 
Control and Supervision of Experiments on Animals), Ministry of Environment and 
Forest, Government of India. 
 
Study design and Controls: 
1) Wistar Albino Rats in controlled age and body weight were selected. 
2) KARUVEPPILAI CHOORANAM was administered at 5mg/kg, 50mg/kg, 
300mg/kg, 2000 mg/kg body weight as water as suspension along with blank. 
3) The results were recorded on the day of drug administration approximately  
1st , 3rd , 4th, 24th hours in post dosing further made in to observation upto 14 
days. 
4) The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22 ±3ºC and the relative humidity was 
maintained between 30-70% with 100% exhaust facility. 
 
EXPERIMENTAL PROCEDURE 
Animals 
   Male Wistar albino rats (150 – 200 gm)  were used for the study. The animals 
were obtained from animal house, Kerala Veterinary and Animal Sciences, 
Mannuthy, Kerala. The animals were placed at random and allocated to treatment 
groups in polypropylene cages with paddy husk as bedding. Animals were housed at a 
temperature of 24±2oC and relative humidity of 30 – 70 %. A 12:12 light:dark  cycle 
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was followed. All animals were allowed to free access to water and fed with standard 
commercial pelleted rat chaw (M/s. Hindustan Lever Ltd, Mumbai). All the 
experimental procedures and protocols used in this study were reviewed by the 
Institutional Animal Ethics Committee, Nandha College of Pharmacy, Erode 
(688/PO/Re/S/02/CPCSEA) and were in accordance with the Institutional ethical 
guidelines (Proposal Number:NCP/IAEC/2018-19/23) 
Test Compound 
 KARUVEPPILAI CHOORANAM  
Administration Procedure 
 Honey was used as vehicle and various doses of KARUVEPPILAI 
CHOORANAM were administered through oral route using gastric gavage tubes to 
animals by suspending in vehicle.  
  The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
Table-1 Group Numbering and Identification animals were marking on body 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
 
  The group no., sex of the animal and animal numbers were identified as 
indicated below using cage label and body marking on the animals. 
Table – 2 Numbering and Identification cage label and body marking                             
on the animals. 
Cage No Group No Animal marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
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  The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
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ACUTE TOXICITY STUDY 
Acute Toxicity Studies 
 Acute toxicity studies were performed according to OECD-423 (Organization 
of Economic and Cooperation Development) guidelines.  
  Male Wister albino rats were selected by random sampling technique were 
employed in this study. The animals were fasted for 4 hr with free access to water. 
The KARUVEPPILAI CHOORANAM was administered orally at a dose of 5 mg/kg 
initially and mortality if any was observed for 3 days. If mortality was observed in 
two out of three animals, then the dose administered was considered as toxic dose. 
However, if the mortality was observed in only one animal out of three animals then 
the same dose was repeated again to confirm the toxic effect. If no mortality was 
observed, then higher (50, 300, 1000 and 2000 mg/kg) doses of the KARUVEPPILAI 
CHOORANAM were employed for further toxicity studies. The following general 
behaviour was also observed during the acute toxicity study (Ecobichon DJ, 1997). 
3.1. Doses: 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighted and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
Table – 3. Doses 
GROUP DOSE 
Group –I Control 
Group – II 5mg/kg 
Group – III 50mg/kg 
Group – IV 300mg/kg 
Group – V 2000mg/kg 
 
 The test substance was administered as single dose. After single dose 
administration period, all animals were observed for 14 days. 
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General Behaviours 
S.No General Behaviour 
1 Sedation 
2 Hypnosis 
3 Convulsion 
4 Ptosis 
5 Analgesia 
6 Stupar Reaction 
7 Motor activity 
8 Muscle Relaxant 
9 CNS Stimulant 
10 CNS Depressant 
11 Pilo Erection 
12 Skin Colour 
13 Lacrimation 
14 Stool Consistancy 
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SUB-ACUTE TOXICITY STUDY 
1.Objective 
 The objective of this ‘Sub-acute toxicity study of KARUVEPPILAI 
CHOORANAM on Wistar Albino Rats’ was to assess the toxicological profile of the 
test substance when treated as a single dose. Animals should be observed for 28 days 
of drug administration. This study provides information on the possible health hazards 
likely to arise from exposure over a relatively limited period of time. 
 
2. Test Guideline followed 
 OECD 407 Method – Sub-Acute Toxic Class Method (Repeated Dose 28-Day 
Oral Toxicity Study in Rodents) 
 
3. Test substance Detail 
 Name: KARUVEPPILAI CHOORANAM 
 Wistar albino rats of either sex weighing 150-200g were used in the study. The 
animals were divided in to 3 groups of 6 animals each.  Group I served as control 
received Distilled water (1ml/kg). Group II & III received the KARUVEPPILAI 
CHOORANAM at the dose of 250 and 500 mg/kg respectively.  
 
Table 4. Animal Groupings 
Groups Drug Treatment 
I Control (1ml/kg, p.o) 
II 
KARUVEPPILAI CHOORANAM 
(250mg/kg, p.o) 
III 
KARUVEPPILAI CHOORANAM  
(500mg/kg, p.o) 
  
Numbering and Identification 
 The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
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Table-5 Group Numbering and Identification animals were marking on body 
Group No Animal marking 
Control H,B,T, HB,BT,HT 
Low dose H,B,T,HB,BT,HT 
High dose H,B,T,HB,BT,HT 
H-head, B-body, T-tail 
 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage . label and body marking on the animals: 
 
Table-6. Dose level 
Cage no Group no Animal marking Sex 
1 Control 
H,B,T Male 
HB,BT,HT Female 
2 Low dose 
H,B,T Male 
HB,BT,HT Female 
3 High dose 
H,B,T Male 
HB,BT,HT Female 
HB – Head Body, BT – Body Tail, HT – Head Tail 
 The vehicle (Honey) and test drugs were administered orally, once daily for 28 
days. Body weight, food intake and water intake were monitored at regular intervals. 
The animals were sacrificed on 29th day for biochemical and histopathological studies. 
Prior to the sacrifice, animals were isolated in individual cages and fasted for 12 hr, 
with water provided ad libitum.  
 Then, they were anaesthetized with pentobarbitone (45mg/kg, i.p) and the 
blood was collected by sino-orbital puncture. Blood samples for the determinations of 
hematological parameters (Ghai, 1995) were collected in heparinized tubes and used 
for the following determinations, hemoglobin (Hb), red blood cell (RBC) count, white 
blood cell (WBC) count and differential count (DC)  
 Non-heparinized tubes were used for serum biochemistry determinations. To 
obtain the serum, blood samples were placed at room temperature for approximately 
30 min. Then, the tubes were centrifuged at 3000 x g for 10 min and the supernatants 
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were taken for the determinations of SGPT (AST), ALT (SGOT), ALP, Creatinine, 
Blood urea nitrogen, Creatinine Phosphokinase and Lactate Dehydrogenase.  
Estimation of AST and ALT 
  Activities of serum Aspartate transaminase (AST) and Alanine transaminase 
(ALT) were assayed by the method of Reitman and Frankel, 1957. 0.2 ml of serum 
with 1 ml of substrate (aspartate and α-ketoglutarate for AST; alanine and α -keto 
glutarate for ALT, in phosphate buffer pH 7.4) was incubated for an hour in case of 
AST and 30 minutes for ALT. 1 ml of DNPH solution was added to arrest the reaction 
and kept for 20 min in room temperature. After incubation 1 ml of 0.4N NaOH was 
added and absorbance was read at 540 nm. Activities expressed as IU/L. 
Estimation of ALP (King, 1965)  
 Set up three test-tubes. Into the 1st (test), added 5 ml of the substrate solution 
(p-nitrophenyl phosphate in glycine/NaOH buffer) followed by 0.1 ml of serum. After 
30 minutes reaction at 370C, the optical density was measured at 405 nm. Into the 2nd 
tube, 5 ml of substrate solution was added with 0.1 ml of serum. After mixing, the 
optical density was measured immediately. Into the 3rd tube, 0.1 ml of water was 
added with 5.0 ml of p – nitrophenol standard solution, optical density was measured.     
Estimation of Blood Urea (Natelson et al., 1951)  
 Labeled three test-tubes as B, T and S. Into B, pipette, 0.02 ml water, into T, 
0.02 ml blood and into S, 0.02 ml standard urea solution (40 mg urea in 100 ml of 
water). 0.1 ml of diacetyl monoxime solution and 5 ml of acid regent 
(Thiosemicarbazide) was added into all the test-tubes. Mixed and kept in a boiling 
water bath for 15 minutes. After cooling, the absorbance was read at 540 nm and 
concentration of urea in mg/dl was calculated.    
 Estimation of Serum Creatinine (Slot, 1965) 
 Labeled three test-tubes as B, T and S. Into B, pipetted, 2 ml of water, into T, 
2 ml serum and 4 ml of water, into S, 3 ml of water and 1 ml of creatinine standard 
(4mg/dl). 2 ml of ammonium sulphate and 2 ml of sodium tungstate was added in all 
the three test-tubes. Centrifuged and removed 3 ml of supernatant from each test tube. 
1 ml of picric acid and distilled water was added to the supernatant of test tubes B, T 
and S. Absorbance was read at 520 nm and concentration of serum creatinine in mg/dl 
was calculated. 
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Determination of Creatine Phosphokinase  
 The activity of CK was estimated by the method of Rosalki (1967).  CK 
catalyses the conversion of creatine phosphate and ADP to creatine and ATP. The 
ATP and glucose are converted to ADP and glucose-6-phosphate by hexokinase 
(HK). Glucose -6-phosphate dehydrogense (G-6-PDH) oxidizes D-glucose-6-
phosphate and reduces the nicotinamide adenine dinucleotide (NAD). The rate of 
NADH formation, measured at 340nm, is directly proportional to serum CK activity. 
One ml of working reagent was added to 50 µl of test sample, mixed and incubated at 
37o C for 1min. After incubation, change in the optical density was measured for 3 
min at an interval of 1min against blank at 340nm. The activity of creatine 
Phosphokinase was expressed as U/L. 
Determination of Lactate Dehydrogenase 
 The activity of LDH was estimated by the method of Teitz,1976. The enzyme 
LDH is distributed in tissues particularly in heart, muscle and kidney. LDH catalyzes 
the oxidation of lactate to pyruvte in the presence of NAD which is subsequently 
reduced to NADH. The rate of NADH formation was measured at 340nm and is 
directly proportional to LDH activity. One ml of the working reagent was added to 10 
µl of test sample, mixed and incubated at 37o C for 1min. After incubation, change in 
the optical density was measured for 1min at an interval of 1 min against reagent 
blank at 340 nm. The activity of LDH was expressed as U/L. 
 After blood collection, the animals were sacrificed by cervical decapitation 
and the organs such as brain, heart, liver, spleen, kidney and testis were removed and 
weighed. The organs were preserved in 10% buffered formaldehyde for 
histopathological observations. 
 
HISTOPATHOLOGICAL STUDIES 
 Anatomy of the liver was studied immediately after sacrificing the animals. A 
small portion was fixed in 10% neutral buffered formalin as described by Luna 14. 
Thin sections of 4-5µm were taken, stained with Haematoxylin and Eosin and 
histology was studied. 
Statistical Analysis 
 The values were expressed as mean ± SEM. The statistical analysis was 
carried out by one way analysis of variance (ANOVA) followed by Dunnett’s‘t’ – test 
using graph pad version I. P values <0.05 were considered significantly. 
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7. RESULT AND INFERENCES 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
 
PHYTO-CHEMICAL STUDY 
This experimental study was taken up to qualitative analysis of Phyto-
chemicals in the drug of Karuveppilai chooranam, using various test and the results 
are exhibited in Table No.7 
Table No 7: Incidence of various phyto-chemicals in Karuveppilai Chooranam 
S.No. Name of Tests Conducted Result Observed 
Observation of Alkaloids 
1. Mayer’s Test Negative 
2. Dragendroff’s Test Negative 
3. Hager’s Test  Negative 
Observation of Carbohydrates and Glycosides 
4. Molisch Test  Positive 
5. Legal’s Test Negative 
6. Borntrager’s Test for anthraquinones Negative 
Observation of Phytosterols 
7. Liebermann – Burchard Test Negative 
8. Salkowski Test Negative 
Observation of Flavanoids 
9. 
Shinoda Test 
(Magnesium turnings & Hydrochloric 
acid) 
Negative 
10. Fluorescence Test Negative 
Observation of Tannins 
11. Ferric chloride test Negative 
12. Potassium dichromate test Negative  
13. Lead acetate test Negative 
14. Millon’s test Negative 
15. Biuret test Negative 
16. Ninhydrin test 
Negative 
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Observation of fixed oils and fats 
17. Spot test Negative 
18. Saponification test Positive 
Observation of Lignin 
19. Phloroglucinol test Negative 
Observation of Saponins 
20. Frothing test Negative 
 Note: Positive indicates the presence of Phytochemical; Negative indicates the absence of 
Phytochemical 
Result 
 Phytochemical analysis of Karuveppilai chooranam shows the presence of 
carbohydrates, glycosides, fixed oils and fats.  
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FOURIER TRANSFORM – INFRARED SPECTROSCOPY  
IR TRACER  - 100 THE NEW FORURIER TRANSFORM INFRARED 
SPECTROPHOTOMETER 
 
 
Chart – 1 FTIR results of Karuveppilai Chooranam 
 
 
Table – 8  Functional group by FTIR study 
 
FREQUENCY cm-1 BOND FUNCTIONAL GROUP 
520.78 C-1 stretching Halo compound 
574.79 C-1 stretching Halo compound 
761.88 C-Cl stretch Aliphatic flouro compound 
866.04 C-H “oop” Aromatic 
1035.77 C-F stretch Aliphatic flouro compound 
1080.14 C-F stretch Aliphatic flouro compound 
1159.22 C-F stretch Aliphatic flouro compound 
1236.37 C-F stretch Aliphatic flouro compound 
1365.60 C-H rock Alkanes 
1743.65 C=O stretching 
 δ-Lactone 
2314.58 P-H stretch Phosphines 
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2353.16 P-H stretch Phosphorus 
2856.58 C-H stretch Alkanes 
2929.87 C-H stretch Alkanes 
S-strong, W-weak, M-medium 
Result: 
 FTIR study of  Karuveppilai chooranam shows the presence of functional 
groups such as Halo compounds, Aliphatic flouro compounds, Aromatics, Alkanes, 
 δ-Lactone , Phosphorus and Phosphines.  
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SEM ANALYSIS 
Scanning Electron Microscope (SEM) 
 
SEM -5000 Magnification 
 
SEM -30000 Magnification 
Result: 
 The particles were stabilized and have irregular morphology. The particles 
were distributed in range10 µm and the size is below 1µm 
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BIO-CHEMICAL ANALYSIS OF KARUVEPPILAI CHOORANAM 
Preparation of the extract:   
  5 grams of the drug was taken in a 250ml clean beaker and 50ml of distilled 
water was added to it.  Then it was boiled welll for about 10minutes.  Then it is 
allowed to cool and filtered in a 100ml volometric flask and made up to 100ml with 
distilled water.  The extract is used for the qualitative analysis. 
Table - 9 
BIO-CHEMICAL ANALYSIS  
S.NO EXPERIMENT OBSERVATION INFERENCE 
1.  
TEST FOR CALCIUM 
2ml of the above prepared extract is taken 
in a clean test tube. To this add 2ml of 4% 
Ammonium oxalate solution 
A white precipitate is 
formed 
Indicates the 
presence of 
calcium 
2. 
TEST FOR SULPHATE 
2ml of the extract is added to 5% Barium 
chloride solution. 
A white precipitate is 
formed 
Indicates the 
presence of 
Chloride 
3.  
TEST FOR CHLORIDE 
The extract is treated with silver nitrate 
solution 
No white precipitate 
is formed 
Absence of 
chloride 
4. 
TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl. 
No Brisk 
effervessence is 
formed 
Absence of 
carbonite 
5. 
 
TEST FOR STARCH 
The extract is added with weak iodine 
solution 
 Blue colour is 
formed 
Indicates the 
presence of 
starch 
6.  
TEST FOR FERRIC IRON 
The extract is acidified with Glacial 
acetic acid and potassium ferro cyanide. 
 
No blue colour is 
formed 
Absence of ferric 
iron 
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7. 
TEST OF FERROUS IRON  
The extract is treated with concentrated 
Nitric acid and Ammonium thio cyanate 
solution 
Blood red colour is 
formed 
Indicates the 
presence of 
ferrous iron 
8.  
TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
Molybdate and concentrated nitric acid 
No yellow 
precipitate is formed 
Absence of 
phosphate 
9.  
TEST FOR ALBUMIN 
The extract is treated with Esbach’s 
reagent 
No Yellow 
precipitate is formed 
Absence of 
albumin 
10.  
TEST FOR TANNIC ACID 
The extract is treated with ferric chloride. 
 Blue black 
precipitate is formed 
Indicates the 
presence of 
tannic acid 
11.  
TEST FOR UNSATURATION 
Potassium permanganate solution is 
added to the extract 
It gets decolourised. 
 
Indicates the 
presence of 
unsaturated 
compound 
12.  
TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 
2 mts and add 8-10 drops of the extract 
and again boil it for 2 mts. 
colour change 
occurs. 
Indicates the 
presence of 
reducing sugar 
13.  
TEST FOR AMINO ACID 
One or two drops of the extract is placed 
on a filter paper and dried well. After 
drying, 1% Ninnhydrin is sprayed over 
the same and dried it well. 
 Violet colour is 
formed 
Indicates the 
presence of 
amino acid 
14. 
TEST FOR ZINC 
The extract is treated with Potassium 
Ferrocyanide. 
No white precipitate 
is formed 
Absence of zinc 
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Inference: 
  Analysis reveals the presence of Calcium, Sulphate, Amino acid, Tannic 
acid, unsaturated compound, Ferrous iron, Starch, and Reducing sugar in 
KARUVEPPILAI CHOORANAM. 
  Biochemical Analyis report was given by Mrs. N.Nagaprema, M.Sc., H.O.D, 
Bio Chemical Department, Government Siddha Medical College, Palayamkottai. 
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ACUTE TOXICITY STUDY ON KARUVEPPILAI CHOORANAM 
 
Effect of Acute Toxicity (14 Days) of KARUVEPPILAI CHOORANAM 
Table 10 Physical and behavioral examinations. 
 
Group no. Dose(mg/kg) Observation sign Mortality 
Group-I Control Normal 0 of 3 
Group- II 5 mg/kg Normal 0 of 3 
Group-III 50 mg/kg Normal 0 of 3 
Group-IV 300 mg/kg Normal 0 of 3 
Group-V 2000 mg/kg Normal 0 of 3 
 
Table – 11 shows the effect of control – Distilled water  ( 1ml/kg ) on general 
behavior after single oral administration in Rat. 
SL NO GENERAL BEHAVIOR 
Time of observation after control – Distilled 
water 
( 1ml/kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table - 12 shows the effect of KARUVEPPILAI CHOORANAM ( 5mg/kg ) on 
general behavior after single oral administration in Rat. 
SL NO 
GENERAL 
BEHAVIOUR 
Time of observation after KARUVEPPILAI 
CHOORANAM 
( 5 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-13  shows the effect of KARUVEPPILAI CHOORANAM ( 50mg/kg ) on 
general behavior after single oral administration in Rat. 
SL NO GENERAL BEHAVIOR 
Time of observation after KARUVEPPILAI 
CHOORANAM 
( 50 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-14  shows the effect of KARUVEPPILAI CHOORANAM ( 300mg/kg ) on 
general behavior after single oral administration in Rat. 
 
SL NO GENERAL BEHAVIOR 
Time of observation after KARUVEPPILAI 
CHOORANAM 
( 300 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-15 shows the effect of KARUVEPPILAI CHOORANAM ( 2000 mg/kg ) on 
general behavior after single oral administration in Rat. 
 
SL NO GENERAL BEHAVIOR 
Time of observation after KARUVEPPILAI 
CHOORANAM 
( 2000 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
 
 
 
 
 
 
 
 
 
69 
 
 
 
Table-16  Home cage activity 
Functional and 
Behavioral 
observation 
O
bs
er
v
a
tio
n
 5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic involuntary 
Movement 
Normal 
behaviour 
3 3 3 3 3 
Tonic involuntary 
Movement 
Normal 
behaviour 
3 3 3 3 3 
Palpebral closure Normal 
behaviour 
3 3 3 3 3 
Approach 
response 
Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response 
Normal 3 3 3 3 3 
 
Table-17  Hand held observation 
Functional and 
Behavioral  
Observation 
O
bs
er
v
a
tio
n
 Control 5 
mg/ kg 
(G-I) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
1000 
mg/kg 
(G-IV) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 3 
Lacrimation Normal 
behaviour 
3 3 3 3 3 3 
Salivation Normal 
behaviour 
3 3 3 3 3 3 
Piloerection Normal 
behaviour 
3 3 3 3 3 3 
Pupillary reflex Normal 3 3 3 3 3 3 
Abdominal tone Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
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Table-18  Mortality 
Group no Dose no(mg/kg) Mortality 
Group-I Control 0 of 3 
Group-II 5 (mg/kg) 0 of 3 
Group-III 50 (mg/kg) 0 of 3 
Group-IV 300 (mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
Results 
The results of acute toxicity study of Karuveppilai Chooranam  was shown on 
table 15. The Karuveppilai Chooranam at all the dose levels (5 to 2000mg/kg) did not 
alter the general behavior after 1hour to 24hours of oral administration. There was no 
mortality with the Karuveppilai Chooranam after 1hr to  24 hrs even at higher dose of 
2000mg/kg. It did not show any lethality or toxic reactions during and after the study. 
From the doses administrated in acute toxicity study, there are two doses 
approximately , 250 and 500 mg/kg were selected for sub-acute toxicity study.  
  
 Table 19. Effect of 
Groups Drug Treatment 
I 
Control – 
Distilled water 
(1ml/kg, p.o) 
II 
Karuveppilai 
Chooranam  
(250mg/kg, p.o) 
III 
Karuveppilai 
Chooranam  
(500mg/kg, p.o) 
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
Figure Effect of Karuveppilai Chooranam 
71 
SUB-ACUTE TOXICITY STUDY 
Karuveppilai Chooranam on body weight during 28 days 
drug administration  in rats 
Body Weight (gms)
1st Day 7th Day 14th Day 
168.73± 
3.42 
176.22± 
4.97 
196.34± 
4.77 
182.50± 
11.52 
190.83± 
9.07 
202.5± 
6.67 
180.83± 
10.16 
190.65± 
18.61 
203.33± 
15.52 
 
s Control 
 on body weight during 28 days 
administration in rats 
 
 
 
21st Day 28th Day 
210.54± 
6.04 
220.22± 
4.40 
215.53± 
8.21 
223.55± 
6.70 
218.33± 
17.63 
228.83± 
13.5 
drug 
 
 Table 20. Effect of Karuveppilai Chooranam 
Groups Drug Treatment
I 
Control - Distilled 
water 
 (1ml/kg, p.o)
II 
Karuveppilai 
Chooranam 
(250mg/kg, p.o)
III 
Karuveppilai 
Chooranam 
(500mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
Figure Effect of Karuveppilai Chooranam 
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 on food intake during 28 days 
administration in rats 
 
Food Intake (gms)
1st Day 7th Day 14th Day 
 
38.42±1.32 42.56±2.86 39.30±2.20 
 
 
55.63±2.97 52.98±3.45 58.22±4.76 
 
 
52.60±3.79 64.70±5.80 59.21±4.88 
 
s Control 
 on food intake during 28 days 
administration in rats 
drug 
 
21st Day 28th Day 
53.75±3.19 56.90±2.72 
55.74±4.2 54.21±4.03 
65.64±4.20 68.00±5.95 
drug 
 Table 21. Effect of 
Groups Drug Treatment
I 
Control – Distilled 
water 
 (1ml/kg, p.o)
II 
Karuveppilai 
Chooranam 
(250mg/kg, p.o)
III 
Karuveppilai 
Chooranam 
(500mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
Figure Effect of Karuveppilai Chooranam 
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Karuveppilai Chooranam  on water intake during 28 days 
drug administration in rats 
 
Water Intake (ml)
1st Day 7th Day 14th Day 
 
51.66± 
2.02 
58.76± 
4.22 
64.00± 
3.90 
 
 
60.72± 
5.43 
85.34± 
6.03 
80.45± 
6.80 
 
 
40.78± 
2.87 
80.25± 
5.76 
60.54± 
5.96 
 
s Control 
 on water intake during 28 days 
administration in rats 
 
21st Day 28th Day 
70.34± 
4.73 
65.76± 
4.80 
90.64± 
5.75 
80.34± 
5.97 
62.54± 
5.95 
85.33± 
5.65 
drug 
 Table 22. Shows the effect of 
in rats after 28 days 
Groups Drug Treatment
I 
Control 
water
(1ml/kg, p.o)
II 
Karuveppilai 
Chooranam 
(250mg/kg, p.o)
III 
Karuveppilai 
Chooranam 
(500mg/kg, p.o)
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
Figure  Shows the effect of 
 
74 
Karuveppilai Chooranam  on RBC, WBC and Hb 
drug administration 
 
RBC million 
cells/cmm 
WBC 
cells/cmm 
– Distilled 
 
 
4.57 ± 
0.16 
8638.52± 
87.66 
 
 
4.37 ± 
0.13 
8615.29± 
191.52 
 
 
3.95 ± 
0.17 
8653.72± 
164.17 
 
s Control 
Karuveppilai Chooranam  on RBC and Hb in rats 
after 28 days drug administration 
 
Haemoglobin 
gm  % 
11.77± 
0.28 
12.00± 
0.27 
10.44± 
0.67 
 
 Figure Shows the effect of 
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Karuveppilai Chooranam  on WBC in rats after 28 
days drug administration 
 
 
 Table . Shows the effect of 
 
Groups 
Drug Treatment
I 
Control 
Distilled water
 (1ml/kg, p.o)
II 
Karuveppilai 
Chooranam 
(250mg/kg, p.o)
III 
Karuveppilai 
Chooranam 
(500mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
 
Figure  Shows the effect of 
76 
Karuveppilai Chooranam  on Differential Count in 
rats after 28 days drug administration 
 
Differential Count
Neutophils Eosinophils Monocyte
– 
 
 
30.00± 
1.79 
1.17± 
0.31 
3.33
0.42
 
 
28.20± 
0.58 
1.60± 
0.21 
3.60
0.25
 
 
29.83± 
0.60 
1.17± 
0.21 
4.17
0.41
 
s Control 
Karuveppilai Chooranam  on Differential Counts in 
rats after 28 days drug administration 
 % 
 Lympocyte 
± 
 
65.83± 
1.64 
± 
 
65.80± 
0.92 
± 
 
65.17± 
1.11 
 
 Table 23 . Shows the effect of 
(SGPT, SGOT and ALP) in rats after 28 days 
 
 
Groups Drug Treatment
I 
Control –
water
 (1ml/kg, p.o)
II 
Karuveppilai 
Chooranam 
(250mg/kg, p.o)
III 
Karuveppilai 
Chooranam 
(500mg/kg, p.o)
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 V
 
Figure  Shows the effect of 
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Karuveppilai Chooranam on Hepatic Functions 
drug administration
 
 
SGPT 
(IU/L) 
SGOT 
(IU/L) 
 Distilled 
 
 
83.83± 
1.42 
150.17± 
4.59 
 
 
90.80± 
5.29 
169.20± 
3.34 
 
 
93.50± 
2.75 
183.67± 
3.20 
 
s Control 
Karuveppilai Chooranam  on Hepatic Functions  in 
rats after 28 days drug administration 
 
ALP 
(IU/L) 
270.83± 
4.17 
276.20± 
4.25 
305.17± 
4.22 
 
  
Table  Shows the effect of 
Groups 
I 
Control 
II 
Karuveppilai Chooranam 
III 
Karuveppilai Chooranam 
 Values are in mean ± SEM (n=6)
 *P<0.05, **P<0.01,
Figure Shows the effect of 
(Blood Urea and Creatinine
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Karuveppilai Chooranam  on Kidney Functions in rats 
after 28 days drug administration 
Drug Treatment 
Urea 
(mg/dl) 
– Distilled water 
 (1ml/kg, p.o) 
34.67± 
1.12 
             
(250mg/kg, p.o) 
38.00± 
2.88 
            
(500mg/kg, p.o) 
60.00± 
2.03 
 
 ***P<0.001 Vs Control 
Karuveppilai Chooranam  on Kidney Functions 
)  in rats after 28 days drug administration
 
Creatinine 
(mg/dl) 
0.84± 
0.07 
0.79± 
0.06 
1.89± 
0.07 
 
 
 Table  Shows the effect of 
 
Groups Drug Treatment
I 
Control 
II 
Karuveppilai Chooranam 
(
III 
Karuveppilai Chooranam 
(5
 Values are in mean ± SEM (n=6)
 *P<0.05, **P<0.01,
Figure Shows the effect of 
(Creatinie Phosphokinase and Lactate Dehydrogenase and in rats after 28 days 
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Karuveppilai Chooranam  on Cardiac Functions in 
rats after 28 days drug administration 
 
Creatinine 
Phosphokinase
(IU/L) 
– Distilled water 
 (1ml/kg, p.o) 
146.83± 
4.79 
 
250mg/kg, p.o) 
159.80± 
8.69 
 
00mg/kg, p.o) 
198.17± 
7.15 
 
 ***P<0.001 Vs Control 
Karuveppilai Chooranam  on Cardiac Functions 
drug administration 
 
 
Lactate 
Dehydrogenase 
(IU/L) 
543.50± 
7.72 
599.80± 
3.73 
752.83± 
8.78 
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HISTOPATHOLOGICAL STUDIES 
 
HEART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
RESULT :   
   Normal cardiac muscle fibers seen 
  
CONTROL LOW DOSE (250mg/kg) 
HIGH DOSE (500mg/kg) 
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LIVER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULT :   
   Normal  Liver parenchyma seen 
  
CONTROL LOW DOSE (250mg/kg) 
HIGH DOSE (500mg/kg) 
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KIDNEY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
RESULT :   
   Normal  Renal parenchyma seen 
  
CONTROL LOW DOSE (250mg/kg) 
HIGH DOSE (500mg/kg) 
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RESULTS 
In sub-acute toxicity study, body weight, food intake and water intake were 
observed on 1st, 7th, 14th 21st and 28th day of Karuveppilai Chooranam after drug 
administration. The effect of Karuveppilai Chooranam regarding body weight during 
28 days treatment in rats was given in table 19 and figure 1. There was no significant 
change in the body weight compared to control with both the doses of Karuveppilai 
Chooranam during 28 days treatment. 
The effect of Karuveppilai Chooranam on food intake during 28 days 
treatment in rats was given in table 20 and figure 2. Karuveppilai Chooranam did not 
alter the food intake at both the dose levels as compared to control during the 28 days 
treatment. It indicates that Karuveppilai Chooranam didn’t have any significant 
influence on food intake.  
The effect of Karuveppilai Chooranam on water intake during 28 days 
treatment in rats was given in table 21 and figure 3. Karuveppilai Chooranam  did not 
alter the water intake at both the dose levels as compared to control during the 28 days 
treatment.  
The effect of Karuveppilai Chooranam on haematological parameters like 
RBC, WBC and Hb in rats after 28 days treatment were given on table 22, figure 4 
and 5. Both the doses of Karuveppilai Chooranam did not showed any significant 
change in RBC, WBC and Hb compared to control.  
The effect of Karuveppilai Chooranam on Differential Count in rats after 28 
days treatment was shown on table 23 and figure 6. Both the doses of Karuveppilai 
Chooranam did not show any significant change in differential counts like 
Neutrophils, Eosinpophils, Monocyte and Lympocytes. From the effect of 
Karuveppilai Chooranam on hematological parameters it was found that it does not 
produce any toxicity in haemopoietic system.   
The effect of Karuveppilai Chooranam  on hepatic functions in rats after 28 
days treatment was shown on table 24 and figure 7. Karuveppilai Chooranam  at low 
dose (250mg/kg) did not produce any significant change in the hepatic enzymes 
(SGPT, SGOT and ALP) and found to be normal. The higher dose (500mg/kg) of 
Karuveppilai Chooranam didn’t alter the SGPT, SGOT and ALP. 
The effect of Karuveppilai Chooranam  on renal functions in rats after 28 days 
treatment was shown on table 25 and figure 8. Karuveppilai Chooranam  at 250mg/kg 
did not showed any significant change in urea and creatinine after 28 days treatment 
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compared to control and also the higher dose 500mg/kg of Karuveppilai Chooranam  
did not showed any significant changes in urea and creatinine.   
The effect of Karuveppilai Chooranam on Cardiac functions in rats after 28 
days treatment was shown on table 26 and figure 9. Low dose of Karuveppilai 
Chooranam (250mg/kg) did not alter the cardiac biomarker enzymes as compared to 
control animals. High dose of Karuveppilai Chooranam (500 mg/kg) significantly did 
not alter the cardiac biomarker enzymes. 
In sub-acute toxicity study shows that Karuveppilai chooranam can be 
considered safe, as it did not cause either and lethality or adverse chanes with general 
behavior of rates and salso there were no observable determental effects on 250mg/kg 
and 500mg/kg over a period of 28days.  It is concluded that the Karuvepppilai 
chooranam is relatively safe when administered orally in human for long 
administration upto the dose 500mg/kg. 
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BIOSTATISTICAL ASPECTS 
Biological assay refers to assessment of the potency of vitamins, hormones, 
toxicants and drugs of all types by means of the responses produced when doses are 
given to experimental animals. In every dose response situation, two components 
must be considered; the stimulus and the subject. 
The stimulus is applied to the subject as a started dose namely concentration, 
weight, time or appropriate measure. The subject manifest a response, the level of 
intensity below which the response does not occur & above which the response occur, 
suh a value has often been called threshold. But the term tolerance is now widely 
accepted. 
MEDIAN EFFECTIVE DOSE (E.D.50) 
 It is the dose which produces the desired response in half the animal 
population tested. 
MEDIAN EFFECTIVE DOSE (E.D.50) 
 It is the dose which kills half the population of the animal tested. 
LD50 Measurement (Toxicity) 
• If the test compound shows any pharmacological activity then the L.D.50 of 
the drug is determined. 
• By determining the L.D.50, we can justify whether to proceed with the drug or 
not. 
Table- 24  Acute toxicity study analysis 
Group Dose in mg/kg No. of rats No. of rats died 
I Distilled water (1ml/kg) 3 - 
II 5 3 - 
III 50 3 - 
IV 300 3 - 
V 2000 3 - 
 
Since there was no mortality of the animal in acute toxicity study, lethal dose 
of drug could not be calculated. 
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Table – 25: Sub – Acute Toxicity Analysis 
Group Dose (mg/kg) Both sex Days No.of rats died 
I Control 3 male + 3 female 28 - 
II 250 3 male + 3 female 28 - 
III 500 3 male + 3 female 28 - 
 
 In case of Sub – Acute Toxicity Study, with the help of physiological 
parameters such as Haematological investigations and with the Histopathological 
studies the drug reaction within the animal can be assessed and are being tabulated 
respectively. 
 Lethal dose of the drug “Karuveippilai Chooranam”can be calculated 
with higher dose level of the drug which can be done in further studies. 
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8. DISCUSSION 
The preclinical toxicity study of Karuveppilai Chooranam was conducted with 
the prime objective to find out whether the drug has possess any side effects or 
adverse reactions on long term administration. 
Biochemical analysis of Karuveppilai Chooranam indicated the presence of 
amino acid, tannic acid, unsaturated compound, ferrous iron, starch and reducing 
sugar. 
Phytochemical analysis of Karuveppilai Chooranam shows the presence of 
carbohydrates, glycosides, fixed oils and fats. 
FTIR study of Karuveppilai Chooranam  shows the presene of halo 
compounds, aliphatic halo compound, aromatics, alkanes, δ- lactone, phosphorus and 
phosphines. 
Scanned Electron Microscope study of end product shows that the particles 
were stabilized and have irregular morphology. The particles were distributed in range 
10µm  and the size is below 1µm 
In acute toxicity study all the animals were active and did not showed any 
signs of toxicity. The motor activities were normal in all the 6 groups of animals.  
This acute toxicity study results reveals that Karuveppilai Chooranam was nontoxic 
upto a dose level of 2000mg/kg body weight of the animal. 
Doses for sub-acute toxicity study were selected on the basis of acute toxicity 
study. The selected doses were 250mg/kg and 500mg/kg  body weight of the animal. 
In sub-acute toxicity study no signs of toxicity were observed. No changes in 
the hematological parameters. There was no changes in food intake, water intake and 
body weight. No mortality occurred till the last day of the study.  
Necropsy study of the major organs liver, kidney and heart showed no 
apparent change in colour. The texture of the organs maintained and the specimens 
were normal on  macroscopical examination when compared with that of the control 
group.  
Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
Since, there was no mortality in both acute and sub-acute toxicity studies the 
lethal dose of the drug could not be calculated. The biostatistical analysis reveals that 
Karuveppilai Chooranam is safe up to a dose level of 2000mg /kg body weight of the 
animal.  
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9. SUMMARY 
The ingredients of Karuveppilai Chooranam were purified and the drug was 
prepared according to the process mentioned in Anuboga vaidhya navaneetham           
(Part – 8, Pg.No. 121, Second Edition - 2002, Hakim P. Mohamed Abdulla Sahib) and 
it was selected for evaluating the toxic effects and mortality when given in short and 
long duration. The aim of this study is to evaluate the safety of the drug Karuveppilai 
Chooranam by administering it to Wistar albino rats at various dose levels.  
In review of literature, the ingredients of Karuveppilai Chooranam were 
discussed in depth with a special attention paid to their medicinal uses and 
toxicological aspects.  
The ingredients of Karuveppilai Chooranam are karuveppilai, sundaivattral, 
mangkottai paruppu, omam, nelli mulli, mathulai odu, venthayam.  All this drugs 
were purchased from Palayamkottai.  The raw samples were taken purification and 
test medicine was prepared, as per the method narrated in the literature. 
Biochemical analysis of Karuveppilai Chooranam indicated the presence of 
amino acid, tannic acid, unsaturated compound, ferrous iron, starch and reducing 
sugar. 
Phytochemical analysis of Karuveppilai Chooranam shows the presence of 
carbohydrates, glycosides, fixed oils and fats. 
FTIR study of Karuveppilai Chooranam shows the presence of halo 
compounds, aliphatic halo compound, aromatics, alkanes, δ- lactone, phosphorus and 
phosphines. 
Scanned Electron Microscope study of end product shows that the particles 
were stabilized and have irregular morphology. The particles were distributed in range 
10µm and the size is below 1 µm 
The Acute toxicity study was conducted to know single dose toxicity of 
Karuveppilai Chooranam on female Wistar Albino Rats. The study was conducted 
using 15 female Wistar Albino Rats. The female animals were selected for study of 6 
weeks old with weight range of within ±20% of mean body weight at the time of 
randomization. The groups were numbered as group I, II, III, IV and V and dose with 
control, 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg of Karuveppilai Chooranam 
The drug was administered by oral route single time and observed for 14 days. Daily 
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the animals were observed for clinical signs and mortality. Body weight of animals 
was recorded once in a week. 
There were no physical and general behavioral changes observed in wistar 
albino rats of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats during 14 days. 
Body weight of all animals did not reveal any significant change as compared 
to vehicle control group.   
Food consumption of all group animals was normal 
Mortality was not observed in all treated groups.  
  In Sub-acute toxicity study,  the animals were selected randomly grouped into 
three different groups containing minimum 6 animals (3male and 3 female in  each 
group) . The groups were numbered as group I, II, III and dose with control, 
250mg/kg (low dose), 500mg/kg (High dose), of  Karuveppilai Chooranam. The 
Karuveppilai Chooranam was administered as single dose for 28 days and all animals 
were observed daily once. These observations were also performed on week ends.  
The observations included clinical signs of toxicity, food intake, water intake, 
body weight. No signs of toxicity were observed. There was no significant changes in 
food intake, water intake and body weight. No mortality occurred till the last day of 
the study. 
The blood samples were used to evaluate Hematological parameters (like 
RBC, WBC, HB,DC) and evaluate biochemical parameters (like SGOT, SGPT, ALP, 
UREA and CREATININE). No changes in haematological parameters and 
biochemical parameters. 
On completion of the 28th day of drug administration, Wistar Albino Rats were 
sacrificed. In macroscopic examination the Heart, Kidneys and Liver organs were 
weighed. The organs were normal when compared with control group. 
Histopathological examination revealed normal architecture in comparison with 
control and drug treated animal. 
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10. CONCLUSION 
 
Karuveppilai Chooranam was studied for its acute and sub-acue toxicity effect 
using laboratory animals. In acute toxicity study, Karuveppilai Chooranam did not 
produce any specific toxicity or mortality even at the dose of 2000mg/kg in wister 
albino rats.So No - Observed – Adverse – Effect – Level (NOAEL) of Karuveppilai 
Chooranam is 2000mg/kg body weight of animal.  In sub-acute toxicity study, 250 
and 500mg/kg of Karuveppilai Chooranam was used and it was administered once 
daily for 28 days through oral route. In conclusion Karuveppilai Chooranam can be 
considered safe, as it did not cause either any lethality or adverse changes with 
general behavior of rats and also there were no observable detrimental effects 
(250mg/kg, 500mg/kg) over a period of 28 days. It is concluded that the Karuveppilai 
Chooranam is relatively safe when administered orally in human for long 
administration upto the dose 500mg/kg.  
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